Medical and Pharmaceutical Biotechnology bachelor degree programme

Would you like to play a part in dramatically improving the quality of life of millions of patients around the world? The Medical and Pharmaceutical Biotechnology bachelor programme will give you the opportunity to do just that.

Biotechnology is one of the world’s fastest growing research disciplines, and there is an urgent need for experts, managers and researchers who are qualified to work in the industry. As a graduate, you will have the expertise to contribute to the development of groundbreaking innovations in the field.

The degree programme: Bachelor of Science in Engineering (BSc)

The Medical and Pharmaceutical Biotechnology bachelor degree is taught in English and comprises theoretical courses and extensive laboratory practicals that cover the fundamentals of natural sciences, biomedicine and the applicable technologies.

It is split into three subject areas:

Medical biotechnology

Lectures and laboratory exercises on biochemical processes, cell and molecular biology, and genetic engineering – including the various analytical techniques – provide a solid knowledge base. You will also gain insights into human medicine and pharmaceutical science in order to acquire an understanding of the effects of medicines and their production.

Pharmaceutical biotechnology

This is an important part of the degree: courses on the theoretical principles and practical implementation of processes used in the biopharmaceutical industry. These cover aspects such as the design of biopharmaceutical production processes and the basics of planning the related production facilities.

In the lab-based courses, a model process set-up is used to illustrate important concepts.

Quality management

Mistakes in the medical and pharmaceutical industry can cost lives, so a thorough knowledge of quality management is essential.

Fundamentals of business

As well as acquiring fundamental scientific knowledge, you also focus on communication and human resources in preparation for working in an interdisciplinary environment.
Your training also includes practical work as part of research and industry projects.

Find out more about the reseach projects

Student Stories

Biotechnology

Biotechnology is an interdisciplinary subject encompassing aspects of medicine, chemistry, biology, physics and pharmacy. Findings from this broad discipline are exploited using integrative approaches.

In this way, they can be implemented to develop biological systems for the production of therapeutic molecules or antibodies for cancer treatments, for instance.

New treatment methods

Biotechnology has developed into a key technology for the future by providing innovative new active substances and diagnostic methods.

There is an increasing focus on stem cells and the cultivation of human tissue in medical biotechnology research. This generates new treatments for previously incurable diseases.

Medical and pharmaceutical technology is by its nature an extremely interdisciplinary field, with the natural sciences, biomedicine and technology playing an especially important role.

Studium Medical and Pharmaceutical Biotechnology - Mann mit Pipette

Studium Medical and Pharmaceutical Biotechnology - Mann und Frau mit Notizbuch

Studium Medical and Pharmaceutical Biotechnology - Frau zeigt auf Landkarte

Medical and pharmaceutical theory combined with extensive lab work: our graduates have a solid foundation on which to build when embarking on careers in biotechnology. They will play a part in tackling problems to which medicine cannot currently provide adequate solutions, and will have the chance to improve the quality of life of people all over the world.

Programme director Harald Hundsberger

A formula for success: theoretical knowledge + practical experience

The programme is built on three pillars.

The basics

Semesters 1-4

You will study a comprehensive range of medical and pharmaceutical biotechnology topics during your degree. Courses at the beginning of the programme cover the fundamentals of science, biomedicine, engineering and analysis in preparation for the more advanced subjects that comes later. The curriculum also includes quality management, business fundamentals, communication and interpersonal skills.

You spend a lot of time in the lab right from the very start. You’re introduced to scientific procedures in small groups, which you put into practice straight away.

The internship

Semester 5

The 22-week compulsory internship comes in semester 5. Over 50% of our Medical and Pharmaceutical Biotechnology students complete their internship abroad at international companies, research institutes or universities.

We provide you with support before and during your internship: you identify your strengths and evaluate your development potential in the course of one-to-one coaching from our internship coordinator, who then helps you to find a suitable internship place at a company in Austria or abroad.

Looking to gain even more international experience? From 2020, students can spend semester 3 or 4 at a high-profile university such as the Dublin Institute of Technology in Ireland or Linköping University in Sweden.

Electives

Semester 6

Towards the end of the programme you opt for one of two electives: the medical biotechnology specialism Production of Therapeutic Proteins or the pharmaceutical biotechnology specialism Drug Development Management.

The goal of medical biotechnology is the replacement of damaged cells or organs, not with transplants or dialysis, but with naturally grown cells. Pharmaceutical biotechnology is concerned with manufacturing medical and pharmaceutical products and related operations. Antibiotics, which are produced with the help of microorganisms in large bioreactors, are examples of established biotechnology products.

Curriculum

What can you expect from your studies? The curriculum provides an overview.
Click on the individual courses for further information.

Semester 1

Course	SWS	ECTS
Introduction to Laboratory
Introduction to Laboratory Techniques	1	1
Introduction to Laboratory Techniques Module: Introduction to Laboratory Root module: Introduction to Laboratory Semester: 1 Course code: ILT1LB Contact hours per week: 1 ECTS: 1 Course Content: Basic techniques for laboratory-based scientific work Safety training and working with safety data sheets Introduction to laboratory equipment (glassware, etc.) Using laboratory equipment (e.g. scales, pH meters and spectrophotometers) Basic laboratory techniques Handling acids, bases and organic solvents Working with indicators Producing solutions and serial dilutions; calculating concentrations and estimating errors Course outcome: Upon completion of this course students are able to: perform the basic practical skills associated with day-to-day laboratory work, produce simple buffers and solutions, apply fundamental measurement techniques such as pH measurement, describe important safety regulations for laboratory work.
Basics of Physics
Applied Physics - Theory	2	3
Applied Physics - Theory Module: Basics of Physics Root module: Basics of Physics Semester: 1 Course code: APT1VO Contact hours per week: 2 ECTS: 3 Course Content: Fundamental physical values Equations of motion Equations of motion on a single plane Force and momentum Movements along an orbit Fields and energy Work and power Material physics Thermodynamics Geometric optics and waves Course outcome: Upon completion of this course students are able to: explain basic physical/scientific principles (f.e Thermodynamics,..), identify physical values that have a significant effect on biotechnological processes.
Applied Physics - Laboratory	3	4
Applied Physics - Laboratory Module: Basics of Physics Root module: Basics of Physics Semester: 1 Course code: APL1LB Contact hours per week: 3 ECTS: 4 Course Content: Working with devices Evaluating measurements and estimating errors Determining the molar mass of an unknown substance Laws of gases Heat transfer Conductivity Viscosity Spectrometers/goniometers Determining heat levels required for melting and evaporation Surface tension Molecular physics Absorption spectra Determining elementary charge Determining the Faraday constant Thermodynamics Course outcome: Upon completion of this course students are able to: perform and interpret simple, yet fundamental physical experiments, record and evaluate results of measurements, estimate errors in the results generated and write reports, explain fundamental physical processes on the basis of experiments.
Basics of Chemistry
Analytical Chemistry Laboratory	2	3
Analytical Chemistry Laboratory Module: Basics of Chemistry Root module: Basics of Chemistry Semester: 1 Course code: ACL1LB Contact hours per week: 2 ECTS: 3 Course Content: Basic day-to-day laboratory methods illustrated using analytical chemistry experiments Qualitative analysis methods: alkali, alkaline-earth and heavy metals, halogens, sulphates and carbonate detection Quantitative analysis methods: gravimetry, various forms of titration (acid-base, redox and complex titration) Equilibrium reactions, reaction kinetics Course outcome: Upon completion of this course students are able to: illustrate key chemistry concepts underpinning biotechnology, and demonstrate and apply this knowledge in examples (e.g. calculations for concentrations, reactions, pH values, etc.), carry out basic qualitative and quantitative analysis methods in the laboratory, apply basic day-to-day laboratory methods illustrated using analytical chemistry experiments.
Chemical Calculations	1	2
Chemical Calculations Module: Basics of Chemistry Root module: Basics of Chemistry Semester: 1 Course code: CC1VO Contact hours per week: 1 ECTS: 2 Course Content: Application-based calculations in a laboratory environment; determining and working with physical units Information on concentrations: calculating molarity, moles, percentages, normality and density Determining the stoichiometry of chemical reactions Classification of inorganic compounds Determining oxidation state; calculating pH values Course outcome: Upon completion of this course students are able to: apply basical calculations underpinning biotechnology in examples (e.g. calculations for concentrations, reactions, pH values, etc.), explain the fundamental scientific principles and laws of chemistry.
General and Inorganic Chemistry	3	4
General and Inorganic Chemistry Module: Basics of Chemistry Root module: Basics of Chemistry Semester: 1 Course code: GIC1VO Contact hours per week: 3 ECTS: 4 Course Content: Introduction to chemistry Importance of mass and units in the natural sciences Atoms and atomic models The periodic table Chemical bonds Chemical equilibrium Fundamentals of thermodynamics Reaction kinetics Properties of the elements and their inorganic compounds Acids and bases Redox reactions Solubility of salts Course outcome: Upon completion of this course students are able to: explain the fundamental scientific principles and laws of chemistry, illustrate key chemistry concepts underpinning biotechnology, and demonstrate and apply this knowledge in examples (e.g. calculations for concentrations, reactions, pH values, etc.).
Fundamentals in Mathematics
Applied Mathematics
Applied Mathematics - Theory	2	3
Applied Mathematics - Theory Module: Applied Mathematics Root module: Fundamentals in Mathematics Semester: 1 Course code: AMTI1VO Contact hours per week: 2 ECTS: 3 Course Content: Performing calculations with indices and logarithms (common and natural logarithms) Solving and applying quadratic equations and functions (linear, quadratic, polynomial, exponential and trigonometric [sin, cos and tan]) Differentiation (first and second derivatives) Integration (standard integrals) Basic principles of statistics: statistical analysis of measurements – samples and population, averages and their graphical representation empirical dispersion (range, linear distribution and empirical standard deviation) Course outcome: Upon completion of this course students are able to: use applied mathematics assumptions and carry out calculations, apply calculations and interpret examples out of biotechnology. practice
Applied Mathematics - Exercise	1	1
Applied Mathematics - Exercise Module: Applied Mathematics Root module: Fundamentals in Mathematics Semester: 1 Course code: AMEI1UE Contact hours per week: 1 ECTS: 1 Course Content: Practical exercises on lecture topics Course outcome: Upon completion of this course students are able to: use applied mathematics assumptions and carry out calculations, calculate and interpret examples out of biotechnology practice.
Introduction to Data Science I	1	1
Introduction to Data Science I Module: Fundamentals in Mathematics Root module: Fundamentals in Mathematics Semester: 1 Course code: IDSI1UE Contact hours per week: 1 ECTS: 1 Course Content: Fundamentals of IT Efficient usage of Microsoft Office applications, in particular Excel (table structures and calculations, graphical analysis of data) Software: commercial applications and open source (databases, statistics programs) Network architecture (company network, process control systems) Course outcome: Upon completion of this course students are able to: explain the basics of computer architecture, and data processing, use Microsoft applications (e.g. Excel) for data processing, anasylis and graphical presentation, explain the basics of data processing using different software applications.
Human Medicine I
Anatomy and Physiology	2	2
Anatomy and Physiology Module: Human Medicine I Root module: Human Medicine I Semester: 1 Course code: AP1VO Contact hours per week: 2 ECTS: 2 Course Content: Cells and their functions Basics of cell communication Tissue structure Anatomy and physiology of organs and blood Homeostasis in the human organism Course outcome: Upon completion of this course students are able to: explain the most important physiological processes in the human body, explain contributions of organs and systems to the maintenance of homeostasis.
Human Genetics	1	2
Human Genetics Module: Human Medicine I Root module: Human Medicine I Semester: 1 Course code: HG1VO Contact hours per week: 1 ECTS: 2 Course Content: Introduction to human genetics Mendelian inheritance Exceptions to Mendel’s laws Sexuality and heredity Multi-factor hereditary characteristics DNA and chromosomes Genetic polymorphism Replication, transcription and translation Mutation and hereditary diseases Population genetics Human evolution Course outcome: Upon completion of this course students are able to: illustrate the complexity and diversity of genetic processes, illustrate the connection between genetic information and cellular structure.
Microbiology
Applied Microbiology	1	2
Applied Microbiology Module: Microbiology Root module: Microbiology Semester: 1 Course code: AM1VO Contact hours per week: 1 ECTS: 2 Course Content: Introduction to microbiology Structure of bacterial cells Bacterial growth, kinetics, media and conditions for growth Growth monitoring and sterilisation Basics of bacterial metabolism Introduction to systematics, and archaea Course outcome: Upon completion of this course students are able to: explain bacterial cells and their growth, explain and evaluate growth monitoring methods and tools, explain and evaluate sterilization methods, illustrate principles of bacterial metabolism and principles of bacterial systematics, compare the differences between bacteria and archea.
Microbiological Working Techniques Laboratory	2	2
Microbiological Working Techniques Laboratory Module: Microbiology Root module: Microbiology Semester: 1 Course code: MWT1LB Contact hours per week: 2 ECTS: 2 Course Content: Students learn about basic techniques in microbiology: Producing media and plates Working under sterile conditions Cultivating and quantifying microorganisms and growth curves Staining methodes Microscopy Growth monitoring and sterilisation Course outcome: Upon completion of the course, students are able to: explain and apply the concept of sterility and recognize sources of contamination, perform basic microbiological methods like growing microorganisms, staining them, using the microscope etc., plan simple experiments, document the experiments properly, analyse critically method and outcome of experiments and sum it up in a written report, Sum up the critical analysis in a presentation and present the results.

Semester 2

Course	SWS	ECTS
Organic Chemistry
Organic Chemistry - Theory	2	3
Organic Chemistry - Theory Module: Organic Chemistry Root module: Organic Chemistry Semester: 2 Course code: OCT2VO Contact hours per week: 2 ECTS: 3 Course Content: Basic concepts of organic chemistry Chemistry of carbon Types of covalent bond Simple hydrocarbon compounds (alkanes, alkenes, alkynes and cycloalkanes) Functional groups in organic chemistry Aromatic and heterocyclic compounds 3D structures and classification of organic compounds (isomers, chirality and conformations) Reaction mechanisms: nucleophiles and electrophiles Substitution reactions Elimination reactions Polymerisation reactions Chemistry of amino acids Alkaloids and carbohydrates Presentation and discussion of basic scientific principles Course outcome: Upon completion of this course students are able to: explain the theoretical principles of organic chemistry, with a focus on component categories and reaction mechanisms, apply practical organic separation and detection skills and synthesise simple organic compounds, explain documentations on synthesis reactions and estimate the related risks.
Organic Chemistry - Laboratory	2	3
Organic Chemistry - Laboratory Module: Organic Chemistry Root module: Organic Chemistry Semester: 2 Course code: OCL2LB Contact hours per week: 2 ECTS: 3 Course Content: Basic organic chemistry techniques and basic synthesis Distillation and detection of alcohol Aspirin synthesis and analysis (thin-layer chromatography, analysing melting points, recrystallisation and UV detection) Producing soap and detergents Carbohydrate analysis Reaction kinetics Vitamin C detection Course outcome: Upon completion of this course students are able to: apply practical organic separation and detection skills and synthesise simple organic compounds, apply documentation on synthesis reactions and estimate the related risks, perform moderate complex laboratory experiments.
Biostatistics and Data Analysis in Biotechnology
Biostatistics	2	4
Biostatistics Module: Biostatistics and Data Analysis in Biotechnology Root module: Biostatistics and Data Analysis in Biotechnology Semester: 2 Course code: BST2VO Contact hours per week: 2 ECTS: 4 Course Content: Descriptive statistics: Averages (arithmetic, geometric and harmonic mean, and median) Dispersion (variance, standard deviation and coefficient of variation) Histograms and frequency distributions Box plots Simple linear regression Inferential statistics: Parametric tests (comparing independent and paired means, analysis of varianceNon-parametric tests (comparing independent and paired means, and analysis of variance) Tests on categorial data Course outcome: Upon completion of this course students are able to: explain the conceptual basis of statistical tests used in the field of biotechnology and life sciences, select suitable statistical tests for biotechnology questions, carry out such tests using relevant software, interpret and analyze the results obtained from biostatistical testing.
Introduction Data Science II	1	2
Introduction Data Science II Module: Biostatistics and Data Analysis in Biotechnology Root module: Biostatistics and Data Analysis in Biotechnology Semester: 2 Course code: IDSII2VO Contact hours per week: 1 ECTS: 2 Course Content: Employ tools for data integration and analysis (e.g. KNIME) for generating workflows aiming at reading in large amounts of data processing data visualizing data analyzing data Course outcome: Upon completion of this course students are able to: implement customized workflows for data analysis and integration, analyze real-life data relevant for life sciences.
Biophysics
Applied Biophysics	2	3
Applied Biophysics Module: Biophysics Root module: Biophysics Semester: 2 Course code: ABP2VO Contact hours per week: 2 ECTS: 3 Course Content: Introduction to electricity (Ohm’s law, Kirchhoff's circuit laws) electromagnetic waves physical principles and characteristics of synthetic and biological membranes, characterisation of biomembrane properties (Langmuir scales, photobleaching, electrons and atomic force microscopy) cell biophysics: cell characterisation methods (determining viscosity, patch clamp, cell electrophoresis, light microscopy, scanning electron microscopy, confocal fluorescence microscopy, cell impedance) radiophysics and its applications in nuclear medicine: principles of nuclear physics, dosimetry, nuclear medical procedures (gamma camera, PET, kinetic examinations, immunoscintigraphy) environmental biophysics. Certain topics will be examined in greater detail using sample calculations and demonstrations. Course outcome: Upon completion of this course students are able to: explain the physical principles and modern analytical methods that underlie biomedicine, explain the principles of nuclear physics, dosimetry, nuclear medical procedures (gamma camera, PET, kinetic examinations, immunoscintigraphy).
Biophysics Laboratory	2	3
Biophysics Laboratory Module: Biophysics Root module: Biophysics Semester: 2 Course code: BPL2LB Contact hours per week: 2 ECTS: 3 Course Content: Experiments will be performed on electricity, magnetism and the following basic biophysical phenomena: sound and sound propagation, phase transitions in polar fluids, characterisation of electrolytes, optical instruments and the characterisation of various sources of visible radiation, partial pressure in gaseous mixtures, radioactivity and adsorption. Course outcome: Upon completion of this course students are able to: apply/use analytical instruments and spectrum interpretation, use operating instructions and other common forms of documentation for the use and maintenance of instruments.
Human Medicine II
Human Diseases	1	1
Human Diseases Module: Human Medicine II Root module: Human Medicine II Semester: 2 Course code: HD2VO Contact hours per week: 1 ECTS: 1 Course Content: Basic physiological principles of regulation, adaptation and homeostasis Central pathophysiological processes in the human organism Key human illnesses, like - Cancer - Immune disorders - Hormonal disorders Course outcome: explain and analyze pathophysiological links, explain and classify common human illnesses, explain biotechnological treatment options.
Immunology and Medical Microbiology	2	2
Immunology and Medical Microbiology Module: Human Medicine II Root module: Human Medicine II Semester: 2 Course code: IMM2VO Contact hours per week: 2 ECTS: 2 Course Content: Structure and function of the immune system Humoral immune responses Cell-mediated immune responses Infectious diseases Human microbiome Viruses Bacterial pathogens Prions, viroids and parasites Options for prevention and therapy Course outcome: illustrate the most important components of the immune system and explain their interplay and communication, classify the different groups of pathogens and explain their interaction with the immune system, Explain preventive methods and therapies, analyze selected topics from immunology and medical microbiology and present them.
Microbiology and Pharmaceutical Production Environment
Microbiological Monitoring Laboratory	2	2
Microbiological Monitoring Laboratory Module: Microbiology and Pharmaceutical Production Environment Root module: Microbiology and Pharmaceutical Production Environment Semester: 2 Course code: MML2LB Contact hours per week: 2 ECTS: 2 Course Content: Basic microbial techniques Surface, air and water monitoring Isolating and identifying bacteria Disinfection and sterilisation Work in accordance with SOPs Preparing SOPs Course outcome: Upon completion of this course students are able to: illustrate the statutory regulations applicable to pharmaceutical production, explain the conditions required for microbial monitoring, exlain and apply surface, air and water monitoring methods in connection with microbes, explain and apply techniques for isolating and identifying microbes, prepare/write and apply standard operating procedures (SOPs), keep records of results, measurements, results of analytical tests and samples, independently plan simple experiments, analyse and present results of the experiments.
Introduction to Contamination Control and Clean Room Training	1	1
Introduction to Contamination Control and Clean Room Training Module: Microbiology and Pharmaceutical Production Environment Root module: Microbiology and Pharmaceutical Production Environment Semester: 2 Course code: CCCT2UE Contact hours per week: 1 ECTS: 1 Course Content: Introduction to statutory regulations applicable to pharmaceutical manufacturing Requirements for clean rooms Description of classes of clean room Principles and flow conditions in clean rooms Demonstration: putting on clean room clothing Familiarisation with and understanding special requirements for working in clean rooms Behaviour in clean rooms Microbiological and particle monitoring methods Minimising contamination in clean rooms Planning clean rooms Course outcome: Upon completion of this course students are able to: summarize the requirements for clean rooms and apply the knowledge for cleanroom concepts, compare/summarize the various classes of clean rooms, apply putting on clean room clothing correctly, compare/summarize and apply the specific requirements for working in clean rooms.
Molecular Biology of the Cell
Cell Biology	2	3
Cell Biology Module: Molecular Biology of the Cell Root module: Molecular Biology of the Cell Semester: 2 Course code: CB2VO Contact hours per week: 2 ECTS: 3 Course Content: Prokaryotic and eukaryotic cells (plant/animal cells) Cell organells: nucleus (chromosomes), endoplasmic reticulum, Golgi apparatus, mitochondria, peroxisomes, endosomes, and lysosomes Biological membrane systems and molecule transport (carrier etc.) Sorting of proteins (from the ER to the cell exterior/)lysosomes/PM Cytoskeleton, intermediate filaments, microtubules and actin Motorproteins Exocytosis and endocytosis Cell migration Mitosis (Cell Division) Course outcome: Upon completion of this course students are able to: compare prokaryotic and eukaryotic cells and between plant and animal cells, explain the function of the various cell compartments and cell organelles, the detailed mechanism of cell division, cell movement and cell clusters, and communication between cells.
Molecular Biology and Genetic Engineering - Theory	2	3
Molecular Biology and Genetic Engineering - Theory Module: Molecular Biology of the Cell Root module: Molecular Biology of the Cell Semester: 2 Course code: MBGE2VO Contact hours per week: 2 ECTS: 3 Course Content: Amino acids and proteins Structure and function of DNA Replication Transcription and checking transcripts Translation Recombination DNA sequencing and PCR Isolating nucleic acids Cloning strategies Vector systems and expressions of recombinant proteins Course outcome: Upon completion of this course students are able to: explain genetic processes such as replication, transcription, translation and recombination, illustrate the theoretical principles for working with nucleic acids, cloning genes and expressing recombinant proteins.

Semester 3

Course	SWS	ECTS
Laboratory Skills for Biotechnology
Instrumental Analytics - Theory	1	2
Instrumental Analytics - Theory Module: Laboratory Skills for Biotechnology Root module: Laboratory Skills for Biotechnology Semester: 3 Course code: IAT3VO Contact hours per week: 1 ECTS: 2 Course Content: • Centrifugation • UV-vis spectroscopy • Fluorescence spectroscopy • Electrophoresis • Chromatography • Mass spectrometry Course outcome: • explain the physical principles and modern analytical methods that underlie biomedicine, • compare main analytical technologies in the area of Biotechnology, Biochemistry and Molecular Biology (f.e. genetic engineering).
Instrumental Analytics - Laboratory	2	3
Instrumental Analytics - Laboratory Module: Laboratory Skills for Biotechnology Root module: Laboratory Skills for Biotechnology Semester: 3 Course code: IAL3LB Contact hours per week: 2 ECTS: 3 Course Content: • Determining cytotoxicity using luminescence spectrometry • PCR and qPCR • Fluorescence spectroscopy • DNA/protein quantification, UV/vis spectroscopy • Chromatography • Performance qualification for analytical instruments Course outcome: • apply main analytical technologies in the area of Biotechnology, Biochemistry and Molecular Biology (f.e. genetic engineering), • work with nucleic acids, • apply calibration and maintain measuring devices, • carry out practical experiments in a quality-controlled environment.
Genetic Engineering Laboratory	2	3
Genetic Engineering Laboratory Module: Laboratory Skills for Biotechnology Root module: Laboratory Skills for Biotechnology Semester: 3 Course code: GEL3LB Contact hours per week: 2 ECTS: 3 Course Content: • Working with E. coli • Transforming E. coli • Plasmid preparation • Restriction digestion • DNA gel electrophoresis • Calibrating pipettes • Spectrophotometrically measurements Course outcome: • apply calibration and maintain measuring devices (f.e.microlitre volume), • perform basic experiments of molecular biology.
Theoretical and Practical Biochemistry
Biochemistry - Theory	3	4
Biochemistry - Theory Module: Theoretical and Practical Biochemistry Root module: Theoretical and Practical Biochemistry Semester: 3 Course code: BCHT3VO Contact hours per week: 3 ECTS: 4 Course Content: The properties of water and aqueous solutions Fundamentals of biological thermodynamics Nucleotides and nucleic acids Amino acids proteins Carbohydrates Lipids and biological membranes Enzymes Introduction to metabolsim Glycolysis, gluconeogenesis and glycogen metabolism Citric acid cycle Oxidative phosphorylation and photosynthesis Fat metabolism Amino acid metabolism Nucleotide metabolism Regulation of metabolic pathways in complex organisms Metabolic disorders, the molecular principles behind them, and therapies Course outcome: Upon completion of this course students are able to: explain the basic physical chemistry principles behind living systems, distinguish between the structural principles of biomolecules in terms of their chemical basis, delineate and asses the metabolic pathways used to produce energy and synthesize biomolecules within organism, explain regulation and the interplay between the most important metabolic pathways.
Biochemistry - Laboratory	2	3
Biochemistry - Laboratory Module: Theoretical and Practical Biochemistry Root module: Theoretical and Practical Biochemistry Semester: 3 Course code: BCHL3LB Contact hours per week: 2 ECTS: 3 Course Content: Producing buffers Biochemistry techniques: dialysis, gel filtration and methods for determining protein content SDS-PAGE, western blotting for serums and quantitative ELISA Enzyme kinetics Risk analysis and evaluation of corresponding experiments Course outcome: Upon completion of this course students are able to: apply state-of-the-art methods for isolating and analyzing biomolecules, use methods learned in the Biostatistics course to analyze the data obtained, analyze and interpret the experimental data generated.
Applied Bioinformatics
Bioinformatics	2	3
Bioinformatics Module: Applied Bioinformatics Root module: Applied Bioinformatics Semester: 3 Course code: BIN3VO Contact hours per week: 2 ECTS: 3 Course Content: Key biological databases and online tools: NCBI, EBI and ExPASy Tools for visualising biomolecules Sequence comparison and alignment of biomolecules Bioinformatics tools used in functional genome analysis Bioinformatics tools used in proteomics Bioinformatics tools in the laboratory: primer design, in silico cloning and calculating biomolecular properties Course outcome: Upon completion of this course students are able to: explain, analyse and interpret sequential and structural differences of biomolecules, use internet tools to analyze the evolutionary relatedness of proteins and nucleic acids, use internet tools and software to analyze the structure, function and properties of biomolecules, explain and use tools for daily laboratory work such as primer design and in silico cloning.
Medical Biology
Cell Physiology and Medical Molecular Biology	2	3
Cell Physiology and Medical Molecular Biology Module: Medical Biology Root module: Medical Biology Semester: 3 Course code: CPMB3VO Contact hours per week: 2 ECTS: 3 Course Content: Cell communication and signal transduction Regulating the cell cycle (G1, DNA synthesis and mitosis) Regulating apoptosis Ion channels and transporters Physiology of nerve cells Structure and physiology of epithelia Stem cells, proliferation and cell differentiation Course outcome: Upon completion of this course students are able to: explain general physiological processes in eukaryotic cells, classify and carry out mechanistic evaluation of individual cell communication and signal transduction pathways.
Cell Culture Techniques	1	1
Cell Culture Techniques Module: Medical Biology Root module: Medical Biology Semester: 3 Course code: CCT3VO Contact hours per week: 1 ECTS: 1 Course Content: Cell culture laboratory equipment: clean benches, incubators, centrifuges and light microscopes Biological safety and hazardous substances Growth media and components Transfection, transduction and transformation Primary cells and cell lines Flow cytometer Confocal microscopy RNAi techniques and the CRISPR/Cas system Assay formats in applied cell biology research Cell disruption and analysis Cell-based testing systems for screening of active ingredients Course outcome: Upon completion of this course students are able to: explain the theoretical principles as well as the advantages and disadvantages of the most important (and most often used) techniques and technologies in modern cell biology.
Cell Culture Laboratory I	2	3
Cell Culture Laboratory I Module: Medical Biology Root module: Medical Biology Semester: 3 Course code: CCL3LB Contact hours per week: 2 ECTS: 3 Course Content: Working under sterile conditions Waste disposal and autoclaving Determining cell counts Thawing and freezing eukaryotic cells Growth curves of eukaryotic cells Passaging suspension cultures and adherent cells Genetic manipulation of cell lines Light and fluorescence microscopy Course outcome: Upon completion of this course students are able to: use equipment and devices used in cell biology research in order to address scientific questions, independently apply fundamental experimental techniques used in cell biology research.
Fundamentals of Engineering
Bioprocess Technology Theory I	1	1
Bioprocess Technology Theory I Module: Fundamentals of Engineering Root module: Fundamentals of Engineering Semester: 3 Course code: BTT3VO Contact hours per week: 1 ECTS: 1 Course Content: Introduction to bioprocess technology Hydrostatics Hydrodynamics Pumping fluids and characteristic curves of pumps Piping Net Positive Suction Head and Total Dynamic Head Course outcome: Upon completion of this course students are able to: explain Hydrostatics and solve corresponding examples, understand Hydrodynamics and solve corresponding examples, apply the Bernoulli-equation to ideal and realistic calculations and solve corresponding tasks, apply/use calculations of Total Dynamic Head and Net Positive Suction Head for instalments.
Measurement and Control Systems I	1	1
Measurement and Control Systems I Module: Fundamentals of Engineering Root module: Fundamentals of Engineering Semester: 3 Course code: MCSI3VO Contact hours per week: 1 ECTS: 1 Course Content: Basics of sensor technology and sensor/control engineering, and their application in biotechnology Fundamentals of electrotechnology Measuring systems (conversion and classification) Sensor design (interfaces, signal processing) Sensor systems (pressure, flow and temperature sensors) Control engineering systems (PI, PD and PID controllers) Course outcome: Upon completion of this course students are able to: explain the fundamental measurement principles of electronics and their application in controllers for bioprocess technology, explain and interpret technical drawings and circuit diagrams, correctly carry out the properties of materials in use.
Quality Management and GLP
Introduction to Quality Management	1	1
Introduction to Quality Management Module: Quality Management and GLP Root module: Quality Management and GLP Semester: 3 Course code: IQM3VO Contact hours per week: 1 ECTS: 1 Course Content: Quality assurance in companies by means of procedural instructions underpinned by specifications and SOPs Quality management in companies (vision, mission, strategy) Quality management cycle Quality controls Indicators Quality assurance Practical exercises in which students draw up and present simple specifications, SOPs or procedural instructions Course outcome: Upon completion of this course students are able to: explain and interpret quality assurance processes for pharmaceuticals, explain and interpret the key statutory regulations applicable to the production of biopharmaceuticals.
GLP/GMP - Theory	1	1
GLP/GMP - Theory Module: Quality Management and GLP Root module: Quality Management and GLP Semester: 3 Course code: GGT3VO Contact hours per week: 1 ECTS: 1 Course Content: Statutory regulations on GLP and the set-up of GLP test laboratories Responsibilities, test set-ups and carrying out studies in accordance with GLP Overview of statutory regulations on GLP and the set-up of production facilities Core aspects of quality management at production facilities in accordance with GLP Quality assurance for biopharmaceuticals produced in accordance with GLP GLP/GMP regulations during biotechnology research and development processes Course outcome: Upon completion of this course students are able to: explain and can apply GLP regulations by planing and generating of study plans, explain and apply Quality Controll at production facilities in accordance with GMP, illustrate and apply GMP regulations by planing and preparing of documents.
Practical Training in Industry
Practical Training Application and Preparation	1	1
Practical Training Application and Preparation Module: Practical Training in Industry Root module: Practical Training in Industry Semester: 3 Course code: PAP3SE Contact hours per week: 1 ECTS: 1 Course Content: Writing CVs and covering letters Career and internship opportunities in industry and research Coaching support with internship applications Course outcome: Upon completion of this course students are able to: generate application documents, choose a suitable place for Practical Training Semester (PTS), illustrate different career paths in biotechnology.

Semester 4

Course	SWS	ECTS
Cell and Tissue Engineering
Cell Culture Laboratory II	3	5
Cell Culture Laboratory II Module: Cell and Tissue Engineering Root module: Cell and Tissue Engineering Semester: 4 Course code: CLLII4LB Contact hours per week: 3 ECTS: 5 Course Content: Theoretical principles: - Cell-based testing of active ingredients - Organotypic 3D cultivation and tissue engineering - Personalised medicine Relationship between genotypes and sensitivity to active ingredients - Tissue engineering methods - Cellular microreactors and their application Practical work: - Engineering blood vessels - Engineering organotypic 3D microtumours - Analysing and quantifying the invasive behaviour of tumour cells and 3D microtumours - Confocal immunofluorescence microscopy: determining the intra-cellular localisation of proteins - Reporter gene assays: quantifying activity in transcription factors Course outcome: Upon completion of this course students are able to: discuss key topical issues in cell biology research, independently plan and carry out complex experimental work, perform qualification and validation of experimental techniques, analyse and interpret data and results.
Scientific Skills	2	3
Scientific Skills Module: Cell and Tissue Engineering Root module: Cell and Tissue Engineering Semester: 4 Course code: SSK4SE Contact hours per week: 2 ECTS: 3 Course Content: Literature databases with a focus on NCBI and PubMed Academic journals and the peer review process Rating, impact factor and academic quality Structure and content of scientific papers Writing academic articles: wording, style and structure (title, introduction, material and methods, results, discussion, references and acknowledgements) Guidelines for the title and introduction Presenting data and results Interpreting and discussing results, taking into account current knowledge Using software to manage references (Endnote, Reference Manager and Mendeley) Original scientific papers, review articles, bachelor, master and doctoral theses Funding scientific work Preparing and submitting research proposals Presenting work packages, milestones and targets Austrian and international funding bodies Fundamentals of scientific communication Communicating with stakeholders Careers in science and research: academia and industry Course outcome: Upon completion of this course students are able to: carry out literature searches in databases, summarise and evaluate the results of experiments in a scientific paper and prepare the paper for publication, explain the peer review process, take part in active scientific discourse.
Pharmaceutical Production Processes
Protein Purification and Bioprocess Technology
Biochemical Analytics, Protein Purification	2	3
Biochemical Analytics, Protein Purification Module: Protein Purification and Bioprocess Technology Root module: Pharmaceutical Production Processes Semester: 4 Course code: BAPP4VO Contact hours per week: 2 ECTS: 3 Course Content: This course outlines the principles behind the following methods: Chromatographic principles (IEX, affinity, HIC, SEC, partition and adsorption) Chromatographic equipment (HPLC, FPLC, GC and SCFC) including detectors Proteomics methods (electrophoresis including CE, and blotting) Spectroscopy methods (UV-Vis, IR, Raman, MS including ionisation, and NMR) Course outcome: Upon completion of this course students are able to: explain analytical methods in chromatography, spectroscopy, electrophoresis, explain and develop analytical processes using principles of chromatography, electrophoresis and spectroscopy.
Equipment and Production Design	2	3
Equipment and Production Design Module: Protein Purification and Bioprocess Technology Root module: Pharmaceutical Production Processes Semester: 4 Course code: EPD4VO Contact hours per week: 2 ECTS: 3 Course Content: Components in biopharmaceutical production facilities (WFI and ultra-pure steam; utilities, description of equipment for the production of cell inoculants, bioreactors) including exercises Downstream equipment Instrumentation in pharmaceutical production facilities QM element: preparing device specifications Course outcome: Upon completion of this course students are able to: illustrate the key components of biotechnology facilities and installations and describe their basic functions, summarize and apply the basic steps involved in commissioning a biotechnology production facility, explain the principles of upstream and downstream processes, apply principles of typical equipment and production design to typical biopharmaceutical tasks.
Bioprocess Technology Theory II	2	4
Bioprocess Technology Theory II Module: Protein Purification and Bioprocess Technology Root module: Pharmaceutical Production Processes Semester: 4 Course code: BPTTII4VO Contact hours per week: 2 ECTS: 4 Course Content: Fundamentals of Reactor Design Fundamentals of Mass Balance Fundamentals of Heat Balance Kinetics in Bioprocess Technology Sterilisiation Techniques Principles of Fermentation Course outcome: Upon completion of this course students are able to: explain and solve problems correlating with mass and heat balances, apply rules of bioprocess kinetics to typcial tasks like fermentation development, explain and apply typical sterilisation procedures, explain and apply principles of balancing, sterilisation and bioprocess kinetics.
Fermentation and Bioseparation Laboratory, Data Analysis	4	6
Fermentation and Bioseparation Laboratory, Data Analysis Module: Pharmaceutical Production Processes Root module: Pharmaceutical Production Processes Semester: 4 Course code: FBL4LB Contact hours per week: 4 ECTS: 6 Course Content: Structure and operation of fermentation in bioreactors Conducting fed-batch fermentation with bacteria Process management and problem-solving In-process and offline analytics Measuring, evaluating and interpreting process parameters during fermentation, and their effect on biological aspects of processes Practical skills required for working with bioreactors under sterile conditions Handling analytical devices (glucose measuring devices, FPLC, etc.) Course outcome: Upon completion of this course students are able to: use scale tasks, pipeline system configurations, pump calculations, power inputs in stirred tanks, and heat and mass balancing at biopharmaceutical plants, use calculations for the configuration and management of biopharmaceutical processes, explain the connections between technology and microbiology, establish quality management principles in pharmaceutical processes.
Applied Quality Management
GLP/GMP - Seminar	2	3
GLP/GMP - Seminar Module: Applied Quality Management Root module: Applied Quality Management Semester: 4 Course code: GGL4SE Contact hours per week: 2 ECTS: 3 Course Content: Core aspects of GMP/GLP in practice / QM Documentation (GDP) Presentation of a GLP laboratory set-up / Theoretical background Detailed describing of experiments and procedures in Study Plan and Study Audit Report (Audit during the laboratory week) Lot Data Sheets Compiling the expected results Writing study reports; SOPs; Course outcome: Upon completion of this course students are able to: identify the basic statutory regulations applicable to biopharmaceutical manufacturing, explain quality assurance processes for pharmaceuticals.
Genetic Engineering Laboratory under GLP	2	3
Genetic Engineering Laboratory under GLP Module: Applied Quality Management Root module: Applied Quality Management Semester: 4 Course code: GELG4LB Contact hours per week: 2 ECTS: 3 Course Content: Advanced molecular biology Independently carrying out a complex experiment planned and prepared by students in GLP/GMP seminar Techniques: DNA isolation, restriction analysis; quantification of DNA; DNA Extraction from agarose gel, agarose electrophoresis, ligation, preparation of competent cells, transformation and colony PCR / GLP documentation of all procedural steps Approaches to GLP-compliant documentation of results generated in experiments and summarising the results in study report Experiments will be carried out in the form of a GLP study Laboratory Audit Course outcome: Upon completion of this course students are able to: independently apply knowledge of regulatory frameworks in practice, and draft SOPs and study plans carry out simple qualification of measuring devices in a quality-controlled environment generate plans for the most common methods and analytical techniques used in molecular biology, apply them under GLP-compliant conditions, and analyse and record the results

Semester 5

Course	SWS	ECTS
Practical Training in Industry
Practical Training Semester	0	25
Practical Training Semester Module: Practical Training in Industry Root module: Practical Training in Industry Semester: 5 Course code: PTS5BOPR Contact hours per week: 0 ECTS: 25 Course Content: The practical training semester is spent in a company or research institution in the field of biotechnology and students learn to know the daily work life in these institutions. Course outcome: Upon completion of this course students are able to: work in the professional field of biotechnology.
Scientific Methods and Tools
Bachelor Paper and Bachelor Exam
Bachelor Seminar I	1	5
Bachelor Seminar I Module: Bachelor Paper and Bachelor Exam Root module: Scientific Methods and Tools Semester: 5 Course code: BAI5BASE Contact hours per week: 1 ECTS: 5 Course Content: Definition of topic for bachelor paper Content and structure of bachelor paper Writing a bachelor paper proposal in accordance with the applicable guidelines Course outcome: Upon completion of this course students are able to: independently write a bachelor paper proposal of the required length which adheres to academic guidelines by a pre-agreed deadline, establish links between their chosen topic and the wider subject area generate and correctly formulate a research question and develop a suitable research methodology, critically reflect on their approach (research questions and methodology).

Semester 6

Course	SWS	ECTS
Pharmaceutical Sciences
Pharmacology	2	4
Pharmacology Module: Pharmaceutical Sciences Root module: Pharmaceutical Sciences Semester: 6 Course code: PHM6VO Contact hours per week: 2 ECTS: 4 Course Content: Pharmacokinetics Pharmacodynamics Pharmacology of the autonomic nervous system Antimicrobial substances Antiviral substances Chemotherapy Allergies and asthma Coagulation Cardiovascular pharmacology Steroid hormones Metabolic syndrome Course outcome: explain the interaction of substances with cells and tissue, explain how medications interfere with signalling pathways in order to produce a therapeutic effect, explain unwanted side effects of medications, explain the administration, spread, excretion, decomposition and toxicity of medications in the human body, differentiate between various categories of substances and mechanisms of action.
Current Issues in Molecular Medicine	2	3
Current Issues in Molecular Medicine Module: Pharmaceutical Sciences Root module: Pharmaceutical Sciences Semester: 6 Course code: CIMM6SE Contact hours per week: 2 ECTS: 3 Course Content: External specialists will be invited to speak about current issues in molecular medicine, giving an insight into their specialist area and working environment. Course outcome: Upon completion of this course students are able to use practical examples from research and industry to evaluate and solve problems associated with substance development.
Project Management
Project Management in Life Sciences	2	3
Project Management in Life Sciences Module: Project Management Root module: Project Management Semester: 6 Course code: PM6VO Contact hours per week: 2 ECTS: 3 Course Content: Projects: targets, focal points, structural plan, definition of work packages, cost budgeting and environmental analysis Corporate organisational structures Project controlling Project reporting and closing Project scorecard Final project report Crises in projects Good Clinical Practice Course outcome: Upon completion of this course students are able to: plan, manage and implement projects in an international environment, plan and execute tasks in the complex, interdisciplinary setting of the pharmaceuticals industry, plan / generate and evaluate a set-up for the implementation of clinical trials, and assess the regulations that underlie them.
Elective Module 1: Production of Therapeutic Proteins
Journal Club for Current Issues
Journal Club for Current Issues	1	2
Journal Club for Current Issues Module: Journal Club for Current Issues Root module: Elective Module 1: Production of Therapeutic Proteins Semester: 6 Course code: S1_JCCI6SE Contact hours per week: 1 ECTS: 2 Course Content: Literature research on the latest trends in the relevant field Reviewing relevant literature Presenting results of the literature review Discussion of contents of the selected literature Course outcome: Upon completion of this course students are able to: structure and analyse scientific articles in their specialist field and use them for their thesis, apply literature research in the relevant field.
Validation and Biomaterials
Introduction to Validation	1	2
Introduction to Validation Module: Validation and Biomaterials Root module: Elective Module 1: Production of Therapeutic Proteins Semester: 6 Course code: S1_IIV6VO Contact hours per week: 1 ECTS: 2 Course Content: Fundamentals of validation: legal principles, validation pyramid, equipment qualification (IQ, OQ, PQ) Basics of test validation (e.g. sensitivity, reproducibility and robustness) Basics of facility validation including an exercise involving the preparation of user requirements specifications and functional specifications Course outcome: Upon completion of this course students are able to: explain and use standard terminology such as qualification and validation in the biotechnology industry, explain and apply fundamentals of validation.
Material Science and Biomaterials	1	2
Material Science and Biomaterials Module: Validation and Biomaterials Root module: Elective Module 1: Production of Therapeutic Proteins Semester: 6 Course code: S1_MSB6VO Contact hours per week: 1 ECTS: 2 Course Content: Classification of chemical substances, general materials science and the properties of materials Material selection for specific facilities and pieces of equipment Biocompatibility of materials Metals and their applications in process technology Plastics and their applications in process technology Course outcome: Upon completion of this course students are able to: explain biopharmaceutical quality documentation and use documentation for new requirements, analyse the properties of materials and select the correct materials for a specific task.
Recombinant Protein Technologies
Measurement and Control Systems II	1	2
Measurement and Control Systems II Module: Recombinant Protein Technologies Root module: Elective Module 1: Production of Therapeutic Proteins Semester: 6 Course code: S1_MSCII6VO Contact hours per week: 1 ECTS: 2 Course Content: Principles of control technology User software applications for control systems: analogue and digital signals, analogue-to-digital and digital-to-analogue converters, microcontrollers, control systems (programmable controllers); incl. independent programming and testing Process control technology theory: the individual components and functions of a biotechnology process control system Course outcome: Upon completion of this course students are able to: analyse control systems and apply them to new situations, create and use control and regulation algorithms.
Pharmaceutical Protein Production Systems	1	2
Pharmaceutical Protein Production Systems Module: Recombinant Protein Technologies Root module: Elective Module 1: Production of Therapeutic Proteins Semester: 6 Course code: S1_PPPS6VO Contact hours per week: 1 ECTS: 2 Course Content: The components of a biotechnology facility, and their installation, commissioning and correct operation Biotechnology production processes illustrated using examples of selected microbial production systems (E. coli, yeasts) and eukaryotic production systems (CHO) Course outcome: Upon completion of this course students are able to: apply and analyse biotechnology processes, explain biotechnology production facilities,
Elective Module 2: Drug Development Management
Journal Club for Current Issues
Journal Club for Current Issues	1	2
Journal Club for Current Issues Module: Journal Club for Current Issues Root module: Elective Module 2: Drug Development Management Semester: 6 Course code: S2_JCCI6SE Contact hours per week: 1 ECTS: 2 Course Content: Literature search on the latest trends in the relevant field Reviewing relevant literature Presenting results of the literature review Discussion of contents of the selected literature Course outcome: Upon completion of this course students are able to: structure and analyse scientific articles in their specialist field and use them for their thesis, apply literature research in the relevant field.
Management and Marketing
Principles of Management and Marketing	2	3
Principles of Management and Marketing Module: Management and Marketing Root module: Elective Module 2: Drug Development Management Semester: 6 Course code: S2_PMM6VO Contact hours per week: 2 ECTS: 3 Course Content: Business objectives and principles Economics (market structures, legal framework) Marketing (market analyses, market strategies) Management and human resource management Management principles Recruitment and training Accounting and management control Financing, procurement, production Operational management Course outcome: Upon completion of this course students are able to: explain and implement marketing strategies in the pharmaceutical industry, apply theoretical marketing knowledge in practice-related situations, anaylse relationships in complex decision-making scenarios and develop effective courses of action as part of a team, illustrate and analyse competition between rival companies, explain and apply the basics of strategic marketing planning.
Biomedical Regulations
Clinical Studies and GCP	1	3
Clinical Studies and GCP Module: Biomedical Regulations Root module: Elective Module 2: Drug Development Management Semester: 6 Course code: S2_CLG6VO Contact hours per week: 1 ECTS: 3 Course Content: Pharmacovigilance, drug safety Informed consent Drug development Documentation Course outcome: Upon completion of this course students are able to: carry out independent critical evaluation of the design and execution of clinical trials, apply the fundamental principles of good clinical practice (GCP) in line with international standards, as well as basic principles of quality and project management.
Drug Regulatory Affairs	1	2
Drug Regulatory Affairs Module: Biomedical Regulations Root module: Elective Module 2: Drug Development Management Semester: 6 Course code: S2_DRA6VO Contact hours per week: 1 ECTS: 2 Course Content: Approval of a new product Efficacy, safety and patient information Labelling of packaging Maintaining approval Required documentation, options for making changes to approvals Course outcome: Upon completion of this course students are able to: explain and apply domestic and international regulatory frameworks for the approval of drugs and medical products, illustrate the content of a marketing approval dossier, explain and apply product information and labelling guidelines.
Scientific Methods and Tools
Bachelor Paper and Bachelor Exam
Bachelor Seminar II and Bachelor Paper	1	8
Bachelor Seminar II and Bachelor Paper Module: Bachelor Paper and Bachelor Exam Root module: Scientific Methods and Tools Semester: 6 Course code: BAII6BASE Contact hours per week: 1 ECTS: 8 Course Content: Composing the bachelor paper based on the research proposal Preparation of bachelor paper including project planning Topic-focused literature research Applying content-related and academic requirements Presentation of selected chapters Course outcome: Upon completion of this course students are able to: independently generate an academic paper in accordance with content-related and formal academic requirements, critically analyse selected chapters of their paper and their significance, discuss the applicability of the results to other cases and questions.
Bachelor Exam	0	2
Bachelor Exam Module: Bachelor Paper and Bachelor Exam Root module: Scientific Methods and Tools Semester: 6 Course code: BEX6AP Contact hours per week: 0 ECTS: 2 Course Content: Presentation of bachelor paper (and project), Oral examination on the bachelor paper (in accordance with section 16 Fachhochschul-Studiengesetz [University of Applied Sciences Studies Act]), and the links to related subjects on the curriculum (in accordance with section 16 University of Applied Sciences Studies Act). Course outcome: Upon completion of this course students are able to: present their bachelor paper and the question they addressed in a manner appropriate to the target audience, and defend the paper before an expert committee, examine the significance of the findings for professional practice and research, and present supporting arguments, answer follow-up questions on degree-programme subjects and the links between them, and justify their answers.

Key features

What makes our Medical and Pharmaceutical Biotechnology programme so special? Here’s an overview.

The Medical and Pharmaceutical Biotechnology bachelor programme is one of the world’s most comprehensive biotechnology degrees focused on red biotechnology, making it compatible with many biomedicine master programmes offered internationally.

Numerous research projects mean that the latest international research topics are frequently integrated into the curriculum, and work for bachelor and master papers is often part of research projects at our Institute for Biotechnology.

Studying and working abroad

Your English-language, industry-focused bachelor degree will lay the foundations for an international career. Half of the lectures and exercises are taught by experts with research or business experience. Many of them come from well-known universities, leading research institutes and research companies in Austria and 22 other countries.

Our university participates in numerous research partnerships with top universities such as Karolinska Institute in Stockholm, Harvard University and the Garvan Institute in Sydney – as well as 3,000 other institutions across the world. The close relations we enjoy with our partners enable you to take advantage of many exchange opportunities and gain international experience.

Another highlight: the Institute for Biotechnology organises an annual scientific conference, which gives our students and alumni the chance to network with international speakers from research and industry.

More about the IMC Life Sciences Week

Lab work: practice makes perfect

As well as acquiring fundamental theoretical knowledge, one of the main objectives of our programme is to equip students with practical skills by including plenty of laboratory work. You do laboratory practicals from the first semester onwards. Importantly: all students are guaranteed a workspace in our state-of-the-art microbiology and molecular biology labs and our chemistry and physics labs.

You also develop a good command of standard research, analysis and production methods, as well as learning basic laboratory skills. Laboratory excises form part of the fundamentals of biology, analysis, biotechnology, bioprocess technology and quality management elements of the programme.

Your 22-week internship – an opportunity to gain first-hand insights into day-to-day research and working life – also gives you additional practical experience.

Excellent career prospects

When you graduate, you can look forward to outstanding job opportunities in the pharmaceutical industry and at technology companies, as well as at research institutes involved in stem cell, regenerative medicine, pharmaceutical development and bioprocess engineering research.

Your impressive skill set will encompass quality control and marketing, and the development, production and approval of biotechnologies for diagnostic and therapeutic applications. The ideal preparation for the jobs of the future.

Newsletter & additional information

Do you need additional information? Subscribe to your personalised newsletter or order brochures about our degree programmes.

Get additional information now

Download brochure now

Newsletter & brochures

Topics *

First name *

Last name *

E-mail *

Language

Yes, I want to receive the selected information from IMC Krems. *

Die mit * makierten Felder sind Pflichtfelder und müssen ausgefüllt werden. Ihre Daten werden selbstverständlich vertraulich behandelt. Weitergabe an Dritte ist ausgeschlossen! Bitte finden Sie die Details zur Verarbeitung Ihrer personenbezogenen Daten in der Datenschutzerklärung insbesondere unter dem Punkt „Newsletterversand“.

Key skills

After graduating from this bachelor degree programme, you will have excellent practical skills in addition to solid professional and scientific abilities.

Find the answers to pressing medical questions

Working in biotechnology gives you the opportunity to tackle problems to which medicine has yet to find satisfactory solutions. The development of antibodies for use in arthritis therapy, and the new technologies for skin transplants and cartilage generation have dramatically improved the quality of life of millions of patients worldwide. And these are only the first outstanding successes of a discipline that is still in its youth.

The expertise to get the job done

On our bachelor programme, you develop specialist know-how in the field of medical and pharmaceutical biotechnology. You learn about the properties of technical and biological materials and their interactions, the fundamentals of electrical engineering, measurement technology in bioprocess technology, control technology, and plant engineering and process development for industry. This means you’re ideally placed to start work in industry or research.

Strong academic foundations

Research plays an essential role in medical and pharmaceutical biotechnology. This is why we help you to develop academic skills that allow you to understand and successfully participate in research processes.

A keen eye for quality

During the degree you develop a thorough knowledge of quality management, acquiring know-how in areas such as legal requirements in the pharmaceutical industry, best practice in clean room operations and clean room monitoring.

Interdisciplinary mindset

Medical and pharmaceutical biotechnology is a very interdisciplinary field. It incorporates insights from microbiology, biochemistry, molecular biology, genetics, engineering and process engineering.

An interdisciplinary mindset and the ability to work effectively with colleagues from different disciplines will be important parts of your day-to-day work, which is why the programme places such a strong emphasis on these aspects.

Career paths

After completing the Medical and Pharmaceutical Biotechnology bachelor degree, you will have excellent career prospects thanks to a curriculum that is closely aligned to the needs of industry and research.

Graduates of the programme are in high demand because of their interdisciplinary training and unique skills profile.

After obtaining your bachelor, you have the choice of starting a career or enrolling for a full-time or part-time master degree. Our tip: the Medical and Pharmaceutical Biotechnologymaster degree is designed to dovetail seamlessly with our bachelor programme.

And, of course, there is the option of taking a related master degree at another Austrian or foreign university.

Potential entry-level positions

biotechnological production and biotechnology process development

routine biomedical laboratory work or applications-based laboratory research

quality assurance for processes and products

approval, marketing and sales of medical products

auditing and inspection of biotechnology products at regulatory and service organisations

10 good reasons

What makes us special? We are more than happy to tell you about the aspects of our university, which we are especially proud of.

Find out more

Krems

Friendly and cosmopolitan: The city attracts students from all over the world, who come to study, research and work together.

Find out more

Service centers

Our university has removed a host of administrative hurdles, leaving you free to concentrate fully on your studies.

Find out more

Advisory Service

Do you have questions regarding our degree programmes or the application? Contact our Prospective Student Advisory Service.

Find out more

Opinions: Medical and Pharmaceutical Biotechnology

Click through the videos of the degree programme.

3 good reasons

1 wrong perception

3 necessary traits

3 career options

3 good reasons for krems

Our info events

Saturday
22.02.2020
09:00
Open House
All information about the bachelor and master degree programmes at IMC Krems.
IMC Campus Krems, Wing G1 IMC Campus Krems, Wing G1
Thursday
19.03.2020
14:00
Bachelor Info Day
All information about the bachelor degree programmes at IMC Krems.
IMC Campus Krems, Wing G1 IMC Campus Krems, Wing G1

Show all events

Our Team

Get to know the core team of our bachelor degree programme Medical and Pharmaceutical Biotechnology.

Prof.(FH) Priv.-Doz. Mag. Dr. Harald Hundsberger
Head of Institute Biotechnology / Programme Director Medical and Pharmaceutical Biotechnology
Institute Biotechnology
Contact
+43 2732 802 521[email protected]
Location
IMC Campus Krems
IMC Campus Trakt G
Core Competencies (2)
Recombinant Protein Expression, Cell Culture Models, Peptide Engineering,
Instrument Development
Active in the degree programmes (2)
Medical and Pharmaceutical Biotechnology
Bachelor of Science in Engineering / full-time
Medical and Pharmaceutical Biotechnology
Master of Science in Engineering / full-time
Projects (14)
Extrazelluläre Vesikel aus dem Hoffa-Fettkörper - ein neuer Ansatz der Knorpelregeneration?
Department of Life Sciences
Testung von rekombinanten polyklonalen Antikörperfragmenten gegen Gluten-Peptide
Project Leader, Department of Life Sciences
Die Rolle von NFR2 in der Melanomprogression - Einblicke in die Mechanismen von Metastasen
Project Leader, Department of Life Sciences
Etablierung der molekularen Toxikologie für rasche, frühzeitige sowie sensitive Toxizitätsbestimmungen und Biokompatibilität
Project Leader, Department of Life Sciences
Entwicklung einer Design-Pipeline für innovative Protein-Protein-Interaktionshemmer
Department of Life Sciences
MEMESA – Metastasierendes Melanom Spezifische Antikörper
Project Leader, Department of Life Sciences
AdsorbTech: Entwicklung einer neuen Technologieplattform für Peptid-basierte therapeutische Apheresesysteme
Project Leader, Department of Life Sciences
Entwicklung neuer immunregulierender Peptide und geschlechtsspezifischer organotypischer Zellmodelle für humane Sepsis
Department of Life Sciences
Entwicklung neuer Methoden zur Verbesserung von immuntherapeutischen Verfahren in der Onkologie
Department of Life Sciences
Funktionale Validierung prädiktiver Biomarker für zielgerichtete Krebstherapien
Department of Life Sciences
Etablierung innovativer, vaskulärer Äquivalente zur Entwicklung von Detektionsmodulen für Hochdurchsatz-Verfahren und zur Entwicklung von anti-entzündlichen Peptiden
Project Leader, Department of Life Sciences
Etablierung innovativer humaner Tumor-Mimetika für das Screening von bioaktiven Wirkstoffen
Department of Life Sciences
Biopharm - Isolation bioaktiver Stoffe aus Cyanobakterien
Project Leader, Department of Life Sciences
Zellbasierte Testsysteme für bioaktive Substanzen
Project Leader, Department of Life Sciences
Publications (30)
[1788]
Hundsberger, H., Stierschneider, A., Sarne, V., Ripper, D., Schimon, J., Weitzenböck, H. P., Schild, D., Jacobi, N., Eger, A., Atzler, J., Klein, C. T., & Wiesner, C. (2021): Concentration-Dependent Pro- and Antitumor Activities of Quercetin in Human Melanoma Spheroids: Comparative Analysis of 2D and 3D Cell Culture Models. Molecules (Basel, Switzerland), 26(3): 717.
Doi: https://doi.org/10.3390/molecules26030717
[1005]
Kinslechner, K., Schütz, B., Pistek, M., Rapolter, P., Weitzenböck, H. P., Hundsberger, H., Mikulits, W., Grillari, J., Röhrl, C., Hengstschläger, M., Stangl, H., & Mikula, M. (2019): Loss of SR-BI Down-Regulates MITF and Suppresses Extracellular Vesicle Release in Human Melanoma. International journal of molecular sciences, 20(5): 1063.
Doi: https://doi.org/10.3390/ijms20051063
[895]
Jacobi, N., Seeboeck, R., Hofmann, E., Schweiger, H., Smolinska, V., Mohr, T., Boyer, A., Sommergruber, W., Lechner, P., Pichler-Huebschmann, C., Önder, K., Hundsberger, H., Wiesner, C., & Eger, A. (2017): Organotypic three-dimensional cancer cell cultures mirror drug responses in vivo: lessons learned from the inhibition of EGFR signaling. Oncotarget, 8(64): 107423–107440.
Doi: https://doi.org/10.18632/oncotarget.22475
[671]
Hundsberger, H., Önder, K., Schuller-Götzburg, P., Virok, D. P., Herzog, J., & Rid, R. (2017): Assembly and use of high-density recombinant peptide chips for large-scale ligand screening is a practical alternative to synthetic peptide libraries. BMC genomics, 18(1): 450.
Doi: https://doi.org/10.1186/s12864-017-3814-3
[900]
Jacobi, N., Smolinska, V., Seeboeck, R., Stierschneider, A., Klein, C., Hofmann, E., Wiesner, C., Mohr, T., Oender, K., Lechner, P., Kaiser, H., Hundsberger, H., Eger, A. (2017): 3D Anti-Cancer drug discovery models: A promising approach for precision medicine. In IMC Fachhochschule Krems GmbH (Hrsg.), Online-Tagungsband FHK Forschungsforum 2017. Krems: FFH.
[657]
Hundsberger, H., Koppensteiner, A., Hofmann, E., Ripper, D., Pflüger, M., Stadlmann, V., Klein, C. T., Kreiseder, B., Katzlinger, M., Eger, A., Forster, F., Missbichler, A., & Wiesner, C. (2017): A Screening Approach for Identifying Gliadin Neutralizing Antibodies on Epithelial Intestinal Caco-2 Cells. SLAS discovery : advancing life sciences R & D, 22(8): 1035–1043.
Doi: https://doi.org/10.1177/2472555217697435
[879]
Volk, K., Breunig, S. D., Rid, R., Herzog, J., Bräuer, M., Hundsberger, H., Klein, C., Müller, N., & Önder, K. (2017): Structural analysis and interaction studies of acyl-carrier protein (acpP) of Staphylococcus aureus, an extraordinarily thermally stable protein. Biological chemistry, 398(1): 125-133.
Doi: https://doi.org/10.1515/hsz-2016-0185
[600]
Schütz, B., Koppensteiner, A., Schörghofer, D., Kinslechner, K., Timelthaler, G., Eferl, R., Hengstschläger, M., Missbichler, A., Hundsberger, H., & Mikula, M. (2016): Generation of metastatic melanoma specific antibodies by affinity purification. Scientific reports, 6: 37253.
Doi: https://doi.org/10.1038/srep37253
[579]
Al-Harthy, T., Zoghaib, W. M., Pflüger, M., Schöpel, M., Önder, K., Reitsammer, M., Hundsberger, H., Stoll, R., & Abdel-Jalil, R. (2016): Design, Synthesis, and Cytotoxicity of 5-Fluoro-2-methyl-6-(4-aryl-piperazin-1-yl) Benzoxazoles. Molecules, 21(10): 1290.
Doi: https://doi.org/10.3390/molecules21101290
[473]
Al-Harthy, T., Abdel-Jalil, R., Zoghaib, W., Pflüger, M., Hofmann, E., & Hundsberger, H. (2016): Design and synthesis of benzothiazole schiff bases of potential antitumor activity. Heterocycles, 92(7): 1282-1292.
Doi: https://doi.org/10.3987/COM-16-13471
[359]
Hofmann, E., Seeboeck, R., Jacobi, N., Obrist, P., Huter, S., Klein, C., Oender, K., Wiesner, C., Hundsberger, H., & Eger, A. (2016): The combinatorial approach of laser-captured microdissection and reverse transcription quantitative polymerase chain reaction accurately determines HER2 status in breast cancer. Biomarker research, 7(4): 8.
Doi: https://doi.org/10.1186/s40364-016-0062-7
[557]
Jacobi, N., Smolinska, V., Stierschneider, A., Klein, C., Oender, K., Lechner, P., Kaiser, H., Hundsberger, H., Eger, A. (2016): Development of organotypic cancer models for the identification of individualized cancer therapies. In FH des BFI Wien (Hrsg.), Online-Tagungsband FHK Forschungsforum 2016. Wien: FFH.
[360]
Herzog, J., Rid, R., Wagner, M., Hundsberger, H., Eger, A., Bauer, J., & Önder, K. (2015): Whole-transcriptome gene expression profiling in an epidermolysis bullosa simplex Dowling-Meara model keratinocyte cell line uncovered novel, potential therapeutic targets and affected pathways. BMC research notes, 8: 785.
Doi: https://doi.org/10.1186/s13104-015-1783-7
[553]
Kreiseder, B., Holper-Schichl, Y. M., Muellauer, B., Jacobi, N., Pretsch, A., Schmid, J. A., de Martin, R., Hundsberger, H., Eger, A., & Wiesner, C. (2015): Alpha-catulin contributes to drug-resistance of melanoma by activating NF-κB and AP-1. PloS one, 10(3): e0119402.
Doi: https://doi.org/10.1371/journal.pone.0119402
[535]
Pretsch, A., Nagl, M., Schwendinger, K., Kreiseder, B., Wiederstein, M., Pretsch, D., Genov, M., Hollaus, R., Zinssmeister, D., Debbab, A., Hundsberger, H., Eger, A., Proksch, P., & Wiesner, C. (2014): Antimicrobial and anti-inflammatory activities of endophytic fungi Talaromyces wortmannii extracts against acne-inducing bacteria. PloS one, 9(6): e97929.
Doi: https://doi.org/10.1371/journal.pone.0097929
[371]
Rid, R., Hundsberger, H., & Onder, K. (2014): Compound screening and transcriptional profiling in human primary keratinocytes: a brief guideline. Methods in molecular biology, 1195: 99-109.
Doi: https://doi.org/10.1007/7651_2013_50
[534]
Kapuścik, A., Hrouzek, P., Kuzma, M., Bártová, S., Novák, P., Jokela, J., Pflüger, M., Eger, A., Hundsberger, H., Kopecký, J. (2013): Novel Aeruginosin-865 from Nostoc sp. as a potent anti-inflammatory agent. Chembiochem : a European journal of chemical biology, 14(17): 2329-2337.
Doi: https://doi.org/10.1002/cbic.201300246
[533]
Rid, R., Herzog, J., Maier, R. H., Hundsberger, H., Eger, A., Hintner, H., Bauer, J. W., Onder, K. (2013): Real-time monitoring of relative peptide-protein interaction strengths in the yeast two-hybrid system. Assay and drug development technologies, 11(4): 269-275.
Doi: https://doi.org/10.1089/adt.2012.496
[842]
Rid, R., Wagner, M., Maier, C. J., Hundsberger, H., Hintner, H., Bauer, J. W., & Onder, K. (2013): Deciphering the calcitriol-induced transcriptomic response in keratinocytes: presentation of novel target genes. Journal of molecular endocrinology, 50(2): 131–149.
Doi: https://doi.org/10.1530/JME-11-0191
[1829]
Kreiseder, B., Orel, L., Bujnow, C., Buschek, S., Pflueger, M., Schuett, W., Hundsberger, H., de Martin, R., Wiesner, C. (2013): α‐Catulin downregulates E‐cadherin and promotes melanoma progression and invasion. International journal of cancer, 132(3): 521-530.
Doi: https://doi.org/10.1002/ijc.27698
[530]
Pflüger, M., Kapuscik, A., Lucas, R., Koppensteiner, A., Katzlinger, M., Jokela, J., Eger, A., Jacobi, N., Wiesner, C., Hofmann, E., Onder, K., Kopecky, J., Schütt, W., Hundsberger, H. (2013): A combined impedance and AlphaLISA-based approach to identify anti-inflammatory and barrier-protective compounds in human endothelium. Journal of biomolecular screening, 18(1): 67-74.
Doi: https://doi.org/10.1177/1087057112458316
[621]
Khare, V., Lyakhovich, A., Dammann, K., Lang, M., Borgmann, M., Tichy, B., Pospisilova, S., Luciani, G., Campregher, C., Evstatiev, R., Pflueger, M., Hundsberger, H., & Gasche, C. (2013): Mesalamine modulates intercellular adhesion through inhibition of p-21 activated kinase-1. Biochemical Pharmacology, 85(2): 234-244.
Doi: https://doi.org/10.1016/j.bcp.2012.10.026
[529]
Maier, C., Maier, R., Rid, R., Trost, A., Hundsberger, H., Eger, A., Hintner, H., Bauer, J., Onder, K. (2012): PIM-1 kinase interacts with the DNA binding domain of the vitamin D receptor: a further kinase implicated in 1,25-(OH)2D3 signaling. BMC molecular biology, 13: 18.
Doi: https://doi.org/10.1186/1471-2199-13-18
[527]
Amatschek, S., Lucas, R., Eger, A., Pflueger, M., Hundsberger, H., Knoll, C., Grosse-Kracht, S., Schuett, W., Koszik, F., Maurer, D., Wiesner, C. (2011): CXCL9 induces chemotaxis, chemorepulsion and endothelial barrier disruption through CXCR3-mediated activation of melanoma cells. British journal of cancer, 104(3): 469-479.
Doi: https://doi.org/10.1038/sj.bjc.6606056
[601]
Hundsberger, H., Verin, A., Wiesner, C., Pflüger, M., Dulebo, A., Schütt, W., Lasters, I., Männel, D., Wendel, A., Lucas, R. (2008): TNF: a moonlighting protein at the interface between cancer and infection. Frontiers in Bioscience, 13: 5374-86.
Doi: https://doi.org/10.2741/3087
[1828]
Hundsberger, H., Verin, A., Wiesner, C., Pflüger, M., Dulebo, A., Schütt, W., Lasters, I., Männel, D. N., Wendel, A., & Lucas, R. (2008): TNF: a moonlighting protein at the interface between cancer and infection. Frontiers in bioscience : a journal and virtual library, 13: 5374–5386.
Doi: https://doi.org/10.2741/3087
[1826]
Wiesner, C., Pflueger, M., Kopecky, J., Stys, D., Entler, B., Lucas, R., Hundsberger, H., Schuett, W. (2008): Implementation of ECIS technology for the characterization of potential therapeutic drugs that promote wound-healing. GMS Krankenhaushygiene interdisziplinar, 3(1).
[622]
Wiesner, C., Pflüger, M., Kopecky, J., Stys, D., Entler, B., Lucas, R., Hundsberger, H., Schütt, W. (2008): Implementation of ECIS technology for the characterization of potential therapeutic drugs that promote wound-healing. GMS Krankenhaushygiene Interdisziplinär, 3(1): Doc05.
[1823]
Wiesner, C., Lucas, R., Pflueger, M., Kleber, C., Kopecky, J., Stys, D., Entler, B., Hundsberger, H., Atzler, J., Hrouzek, P., Lukesova, A., Schuett, W., (2007): Endothelial Cell-Based Methods for the Detection of Cyanobacterial Anti- Inflammatory and Wound-Healing Promoting Metabolites. Drug Metabolism Letters, 1(4): 254-260.
Doi: https://doi.org/10.2174/187231207783221385
[1822]
Lucas, R., Hundsberger, H., Pflueger, M., Fischer, B., Morel, D., Braun, C., Wendel, A., Chakraborty, T., Schuett, W., Wiesner, C., Hamacher, J. (2007): The Tumor Necrosis Factor-Derived TIP Peptide: A Potential Anti-Edema Drug. Letters in Drug Design & Discovery, 4(5): 336-340.
Doi: https://doi.org/10.2174%2F157018007780867816
Head of Institute Biotechnology / Programme Director Medical and Pharmaceutical Biotechnology
Prof.(FH) Priv.-Doz. Mag. Dr. Harald Hundsberger
+43 2732 802 521 [email protected]
Core Competencies
Recombinant Protein Expression, Cell Culture Models, Peptide Engineering,Instrument Development

Full-time Lecturers

Mag. Dr. Peter Allacher
Laboratory Head / Institute Krems Bioanalytics
Institute Krems Bioanalytics
Contact
+43 2732 802 281[email protected]
Location
IMC TFZ
IMC TFZ Haupthaus
Active in the degree programmes (1)
Medical and Pharmaceutical Biotechnology
Bachelor of Science in Engineering / full-time
Publications (9)
[555]
Lubich, C., Allacher, P., de la Rosa, M., Bauer, A., Prenninger, T., Horling, F. M., Siekmann, J., Oldenburg, J., Scheiflinger, F., & Reipert, B. M. (2016): The Mystery of Antibodies Against Polyethylene Glycol (PEG) - What do we Know?. Pharmaceutical research, 33(9): 2239-49.
Doi: https://doi.org/10.1007/s11095-016-1961-x
[556]
Jaki, T., Allacher, P., & Horling, F. (2016): A false sense of security? Can tiered approach be trusted to accurately classify immunogenicity samples?. Journal of pharmaceutical and biomedical analysis, 128: 166-73.
Doi: https://doi.org/10.1016/j.jpba.2016.05.031
[1726]
Hofbauer, C.J., Whelan,S.F.J., Hirschler, M., Allacher, P., Horling, F.M., Lawo, J.-P., Oldenburg, J., Tiede, A., Male, C., Windyga, J., Greinacher, A., Knöbl, P.N., Schrenk, G., Koehn, J., Scheiflinger, F., Reipert, B.M. (2015): Affinity of FVIII-specific antibodies reveals major differences between neutralizing and nonneutralizing antibodies in humans. Blood, 125(7): 1180-1188.
Doi: https://doi.org/10.1182/blood-2014-09-598268
[1770]
Jaki, T., Lawo, J.-P., Wolfsegger, M.J., Allacher, P., Horling, F. (2014): A comparison of methods for classifying samples as truly specific with confirmatory immunoassays. Journal of pharmaceutical and biomedical analysis, 88: 27-35.
Doi: https://doi.org/10.1016/j.jpba.2013.08.013
[1728]
Whelan, S. F., Hofbauer, C. J., Horling, F. M., Allacher, P., Wolfsegger, M. J., Oldenburg, J., Male, C., Windyga, J., Tiede, A., Schwarz, H. P., Scheiflinger, F., & Reipert, B. M. (2013): Distinct characteristics of antibody responses against factor VIII in healthy individuals and in different cohorts of hemophilia A patients. Blood, 121(6): 1039-1048.
Doi: https://doi.org/10.1182/blood-2012-07-444877
[1767]
Pordes, A. G., Baumgartner, C. K., Allacher, P., Ahmad, R. U., Weiller, M., Schiviz, A. N., Schwarz, H. P., & Reipert, B. M. (2011): T cell-independent restimulation of FVIII-specific murine memory B cells is facilitated by dendritic cells together with toll-like receptor 7 agonist. Blood, 118(11): 3154–3162.
Doi: https://doi.org/10.1182/blood-2011-02-336198
[1727]
Jaki, T., Lawo, J.-P., Wolfsegger, M.J., Singer, J., Allacher, P., Horling, F. (2011): A formal comparison of different methods for establishing cut points to distinguish positive and negative samples in immunoassays. Journal of pharmaceutical and biomedical analysis, 55(5): 1148-1156.
Doi: https://doi.org/10.1016/j.jpba.2011.04.006
[1768]
Allacher, P., Baumgartner, C. K., Pordes, A. G., Ahmad, R. U., Schwarz, H. P., & Reipert, B. M. (2011): Stimulation and inhibition of FVIII-specific memory B-cell responses by CpG-B (ODN 1826), a ligand for Toll-like receptor 9. Blood, 117(1): 259-267.
Doi: https://doi.org/10.1182/blood-2010-06-289009
[1725]
Reipert, B. M., Allacher, P., Hausl, C., Pordes, A. G., Ahmad, R. U., Lang, I., Ilas, J., Windyga, J., Klukowska, A., Muchitsch, E. M., & Schwarz, H. P. (2010): Modulation of factor VIII-specific memory B cells. Haemophilia, 16(102): 25-34.
Doi: https://doi.org/10.1111/j.1365-2516.2008.01962.x
Mag. Dr. Peter Allacher
A
Laboratory Head / Institute Krems Bioanalytics
Prof.(FH) Priv. Doz. Mag. Dr. Andreas Eger
Head of Research Institute Krems Bioanalytics / Professor Department of Life Sciences
Institute Krems Bioanalytics
Contact
+43 2732 802 369[email protected]
Location
IMC Campus Krems
IMC Campus Trakt G
Core Competencies (3)
Drug Discovery
Organotypic Disease Models
Bioanalytics and Biomarker
Active in the degree programmes (2)
Medical and Pharmaceutical Biotechnology
Master of Science in Engineering / full-time
Medical and Pharmaceutical Biotechnology
Bachelor of Science in Engineering / full-time
Projects (10)
Stoffwechsel-Plasma-Analyse bei metabolischem Syndrom und Tumorkachexie
Project Leader, Department of Life Sciences
DNA Methylierung im Lungenkrebs und ihre geschlechtsspezifische Auswirkung auf die Effizienz epigenetischer Therapien
Department of Life Sciences
Entwicklung von therapeutischen Peptiden für Krebs- und regenerative Medizin
Project Leader, Department of Life Sciences
Etablierung der molekularen Toxikologie für rasche, frühzeitige sowie sensitive Toxizitätsbestimmungen und Biokompatibilität
Department of Life Sciences
Entwicklung komplexer extrakorporaler Karzinommodelle für die Identifikation personalisierter Krebstherapien
Project Leader, Department of Life Sciences
AdsorbTech: Entwicklung einer neuen Technologieplattform für Peptid-basierte therapeutische Apheresesysteme
Department of Life Sciences
Entwicklung neuer immunregulierender Peptide und geschlechtsspezifischer organotypischer Zellmodelle für humane Sepsis
Department of Life Sciences
Entwicklung neuer Methoden zur Verbesserung von immuntherapeutischen Verfahren in der Onkologie
Project Leader, Department of Life Sciences
Funktionale Validierung prädiktiver Biomarker für zielgerichtete Krebstherapien
Project Leader, Department of Life Sciences
Etablierung innovativer humaner Tumor-Mimetika für das Screening von bioaktiven Wirkstoffen
Project Leader, Department of Life Sciences
Publications (35)
[1788]
Hundsberger, H., Stierschneider, A., Sarne, V., Ripper, D., Schimon, J., Weitzenböck, H. P., Schild, D., Jacobi, N., Eger, A., Atzler, J., Klein, C. T., & Wiesner, C. (2021): Concentration-Dependent Pro- and Antitumor Activities of Quercetin in Human Melanoma Spheroids: Comparative Analysis of 2D and 3D Cell Culture Models. Molecules (Basel, Switzerland), 26(3): 717.
Doi: https://doi.org/10.3390/molecules26030717
[895]
Jacobi, N., Seeboeck, R., Hofmann, E., Schweiger, H., Smolinska, V., Mohr, T., Boyer, A., Sommergruber, W., Lechner, P., Pichler-Huebschmann, C., Önder, K., Hundsberger, H., Wiesner, C., & Eger, A. (2017): Organotypic three-dimensional cancer cell cultures mirror drug responses in vivo: lessons learned from the inhibition of EGFR signaling. Oncotarget, 8(64): 107423–107440.
Doi: https://doi.org/10.18632/oncotarget.22475
[900]
Jacobi, N., Smolinska, V., Seeboeck, R., Stierschneider, A., Klein, C., Hofmann, E., Wiesner, C., Mohr, T., Oender, K., Lechner, P., Kaiser, H., Hundsberger, H., Eger, A. (2017): 3D Anti-Cancer drug discovery models: A promising approach for precision medicine. In IMC Fachhochschule Krems GmbH (Hrsg.), Online-Tagungsband FHK Forschungsforum 2017. Krems: FFH.
[896]
Jacobi, N., Seeboeck, R., Hofmann, E., & Eger, A. (2017): ErbB Family Signalling: A Paradigm for Oncogene Addiction and Personalized Oncology. Cancers, 9(4): 33.
Doi: https://doi.org/10.3390/cancers9040033
[657]
Hundsberger, H., Koppensteiner, A., Hofmann, E., Ripper, D., Pflüger, M., Stadlmann, V., Klein, C. T., Kreiseder, B., Katzlinger, M., Eger, A., Forster, F., Missbichler, A., & Wiesner, C. (2017): A Screening Approach for Identifying Gliadin Neutralizing Antibodies on Epithelial Intestinal Caco-2 Cells. SLAS discovery : advancing life sciences R & D, 22(8): 1035–1043.
Doi: https://doi.org/10.1177/2472555217697435
[359]
Hofmann, E., Seeboeck, R., Jacobi, N., Obrist, P., Huter, S., Klein, C., Oender, K., Wiesner, C., Hundsberger, H., & Eger, A. (2016): The combinatorial approach of laser-captured microdissection and reverse transcription quantitative polymerase chain reaction accurately determines HER2 status in breast cancer. Biomarker research, 7(4): 8.
Doi: https://doi.org/10.1186/s40364-016-0062-7
[557]
Jacobi, N., Smolinska, V., Stierschneider, A., Klein, C., Oender, K., Lechner, P., Kaiser, H., Hundsberger, H., Eger, A. (2016): Development of organotypic cancer models for the identification of individualized cancer therapies. In FH des BFI Wien (Hrsg.), Online-Tagungsband FHK Forschungsforum 2016. Wien: FFH.
[360]
Herzog, J., Rid, R., Wagner, M., Hundsberger, H., Eger, A., Bauer, J., & Önder, K. (2015): Whole-transcriptome gene expression profiling in an epidermolysis bullosa simplex Dowling-Meara model keratinocyte cell line uncovered novel, potential therapeutic targets and affected pathways. BMC research notes, 8: 785.
Doi: https://doi.org/10.1186/s13104-015-1783-7
[553]
Kreiseder, B., Holper-Schichl, Y. M., Muellauer, B., Jacobi, N., Pretsch, A., Schmid, J. A., de Martin, R., Hundsberger, H., Eger, A., & Wiesner, C. (2015): Alpha-catulin contributes to drug-resistance of melanoma by activating NF-κB and AP-1. PloS one, 10(3): e0119402.
Doi: https://doi.org/10.1371/journal.pone.0119402
[536]
Bakiri, L., Macho-Maschler, S., Custic, I., Niemiec, J., Guío-Carrión, A., Hasenfuss, S. C., Eger, A., Müller, M., Beug, H., & Wagner, E. F. (2015): Fra-1/AP-1 induces EMT in mammary epithelial cells by modulating Zeb1/2 and TGFβ expression. Cell death and differentiation, 22(2): 336–350.
Doi: https://doi.org/10.1038/cdd.2014.157
[498]
Spilka, R., Ernst, C., Bergler, H., Rainer, J., Flechsig, S., Vogetseder, A., Lederer, E., Benesch, M., Brunner, A., Geley, S., Eger, A., Bachmann, F., Doppler, W., Obrist, P., & Haybaeck, J. (2014): eIF3a is over-expressed in urinary bladder cancer and influences its phenotype independent of translation initiation. Cellular oncology (Dordrecht), 37(4): 253–267.
Doi: https://doi.org/10.1007/s13402-014-0181-9
[535]
Pretsch, A., Nagl, M., Schwendinger, K., Kreiseder, B., Wiederstein, M., Pretsch, D., Genov, M., Hollaus, R., Zinssmeister, D., Debbab, A., Hundsberger, H., Eger, A., Proksch, P., & Wiesner, C. (2014): Antimicrobial and anti-inflammatory activities of endophytic fungi Talaromyces wortmannii extracts against acne-inducing bacteria. PloS one, 9(6): e97929.
Doi: https://doi.org/10.1371/journal.pone.0097929
[534]
Kapuścik, A., Hrouzek, P., Kuzma, M., Bártová, S., Novák, P., Jokela, J., Pflüger, M., Eger, A., Hundsberger, H., Kopecký, J. (2013): Novel Aeruginosin-865 from Nostoc sp. as a potent anti-inflammatory agent. Chembiochem : a European journal of chemical biology, 14(17): 2329-2337.
Doi: https://doi.org/10.1002/cbic.201300246
[533]
Rid, R., Herzog, J., Maier, R. H., Hundsberger, H., Eger, A., Hintner, H., Bauer, J. W., Onder, K. (2013): Real-time monitoring of relative peptide-protein interaction strengths in the yeast two-hybrid system. Assay and drug development technologies, 11(4): 269-275.
Doi: https://doi.org/10.1089/adt.2012.496
[530]
Pflüger, M., Kapuscik, A., Lucas, R., Koppensteiner, A., Katzlinger, M., Jokela, J., Eger, A., Jacobi, N., Wiesner, C., Hofmann, E., Onder, K., Kopecky, J., Schütt, W., Hundsberger, H. (2013): A combined impedance and AlphaLISA-based approach to identify anti-inflammatory and barrier-protective compounds in human endothelium. Journal of biomolecular screening, 18(1): 67-74.
Doi: https://doi.org/10.1177/1087057112458316
[532]
Imhof, M., Karas, I., Gomez, I., Eger, A., & Imhof, M. (2013): Interaction of tumor cells with the immune system: implications for dendritic cell therapy and cancer progression. Drug discovery today, 18(1-2): 35-42.
Doi: https://doi.org/10.1016/j.drudis.2012.07.010
[529]
Maier, C., Maier, R., Rid, R., Trost, A., Hundsberger, H., Eger, A., Hintner, H., Bauer, J., Onder, K. (2012): PIM-1 kinase interacts with the DNA binding domain of the vitamin D receptor: a further kinase implicated in 1,25-(OH)2D3 signaling. BMC molecular biology, 13: 18.
Doi: https://doi.org/10.1186/1471-2199-13-18
[528]
Vonach, C., Viola, K., Giessrigl, B., Huttary, N., Raab, I., Kalt, R., Krieger, S., Vo, T. P., Madlener, S., Bauer, S., Marian, B., Hämmerle, M., Kretschy, N., Teichmann, M., Hantusch, B., Stary, S., Unger, C., Seelinger, M., Eger, A., Mader, R., Jäger, W., Schmidt, W., Grusch, M., Dolznig, H., Mikulits, W., Krupitza, G. (2011): NF-κB mediates the 12(S)-HETE-induced endothelial to mesenchymal transition of lymphendothelial cells during the intravasation of breast carcinoma cells. British journal of cancer, 105(2): 263-271.
Doi: https://doi.org/10.1038/bjc.2011.194
[527]
Amatschek, S., Lucas, R., Eger, A., Pflueger, M., Hundsberger, H., Knoll, C., Grosse-Kracht, S., Schuett, W., Koszik, F., Maurer, D., Wiesner, C. (2011): CXCL9 induces chemotaxis, chemorepulsion and endothelial barrier disruption through CXCR3-mediated activation of melanoma cells. British journal of cancer, 104(3): 469-479.
Doi: https://doi.org/10.1038/sj.bjc.6606056
[526]
Spaderna, S., Schmalhofer, O., Wahlbuhl, M., Dimmler, A., Bauer, K., Sultan, A., Hlubek, F., Jung, A., Strand, D., Eger, A., Kirchner, T., Behrens, J., & Brabletz, T. (2008): The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer. Cancer research, 68(2): 537–544.
Doi: https://doi.org/10.1158/0008-5472.CAN-07-5682
[525]
Mikula M., Lahsnig C., Fischer A. N. M., Proell V., Huber H, Fuchs E., Eger A., Beug H. and Mikulits W. (2007): Epithelial plasticity of hepatocytes during liver tumor progression. Stem cells and their potential for clinical application. NATO Science for Peace and Security. Series/NATO Science Foundation. Springer Netherland, Edition 1.
[523]
Aigner, K., Dampier, B., Descovich, L., Mikula, M., Sultan, A., Schreiber, M., Mikulits, W., Brabletz, T., Strand, D., Obrist, P., Sommergruber, W., Schweifer, N., Wernitznig, A., Beug, H., Foisner, R., & Eger, A. (2007): The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity. Oncogene, 26(49): 6979–6988.
Doi: https://doi.org/10.1038/sj.onc.1210508
[524]
Aigner, K., Descovich, L., Mikula, M., Sultan, A., Dampier, B., Bonné, S., van Roy, F., Mikulits, W., Schreiber, M., Brabletz, T., Sommergruber, W., Schweifer, N., Wernitznig, A., Beug, H., Foisner, R., & Eger, A. (2007): The transcription factor ZEB1 (deltaEF1) represses Plakophilin 3 during human cancer progression. FEBS letters, 581(8): 1617-24.
Doi: https://doi.org/10.1016/j.febslet.2007.03.026
[507]
Pacher, M., Seewald, M. J., Mikula, M., Oehler, S., Mogg, M., Vinatzer, U., Eger, A., Schweifer, N., Varecka, R., Sommergruber, W., Mikulits, W., & Schreiber, M. (2007): Impact of constitutive IGF1/IGF2 stimulation on the transcriptional program of human breast cancer cells. Carcinogenesis, 28(1): 49-59.
Doi: https://doi.org/10.1093/carcin/bgl091
[506]
Spaderna, S., Schmalhofer, O., Hlubek, F., Berx, G., Eger, A., Merkel, S., Jung, A., Kirchner, T., & Brabletz, T. (2006): A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer. Gastroenterology, 131(3): 830–840.
Doi: https://doi.org/10.1053/j.gastro.2006.06.016
[505]
Stary, M., Pasteiner, W., Summer, A., Hrdina, A., Eger, A., & Weitzer, G. (2005): Parietal endoderm secreted SPARC promotes early cardiomyogenesis in vitro. Experimental cell research, 310(2): 331-43.
Doi: https://doi.org/10.1016/j.yexcr.2005.07.013
[496]
Eger, A., Mikulits, W. (2005): Models of Epithelial to Mesenchymal Transition. Drug Discovery Today: Disease Models, 2(1): 57-63.
Doi: https://doi.org/10.1016/j.ddmod.2005.04.001
[495]
Eger, A., Aigner, K., Sonderegger, S., Dampier, B., Oehler, S., Schreiber, M., Berx, G., Cano, A., Beug, H., & Foisner, R. (2005): DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells. Oncogene, 24(14): 2375-85.
Doi: https://doi.org/10.1038/sj.onc.1208429
[494]
Eger, A., Stockinger, A., Park, J., Langkopf, E., Mikula, M., Gotzmann, J., Mikulits, W., Beug, H., & Foisner, R. (2004): β-catenin and TGFβ signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition. Oncogene, 23(15): 2672-2680.
Doi: https://doi.org/10.1038/sj.onc.1207416
[493]
Gotzmann, J., Mikula, M., Eger, A., Schulte-Hermann, R., Foisner, R., Beug, H., & Mikulits, W. (2004): Molecular aspects of epithelial cell plasticity: implications for local tumor invasion and metastasis. Mutation research, 566(1): 9–20.
Doi: https://doi.org/10.1016/s1383-5742(03)00033-4
[492]
Stockinger, A., Eger, A., Wolf, J., Beug, H., & Foisner, R. (2001): E-cadherin regulates cell growth by modulating proliferation-dependent beta-catenin transcriptional activity. The Journal of cell biology, 154(6): 1185–1196.
Doi: https://doi.org/10.1083/jcb.200104036
[491]
Eger A. and Foisner R. (2000): Dynamic and cross talk of junctional proteins: a molecular basis for the regulation of cell adhesion and epithelial polarity. Protoplasma, 211(3-4): 125-133.
[490]
Eger, A., Stockinger, A., Schaffhauser, B., Beug, H., & Foisner, R. (2000): Epithelial mesenchymal transition by c-Fos estrogen receptor activation involves nuclear translocation of beta-catenin and upregulation of beta-catenin/lymphoid enhancer binding factor-1 transcriptional activity. The Journal of cell biology, 148(1): 173-188.
Doi: https://doi.org/10.1083/jcb.148.1.173
[489]
Gotzmann, J., Eger, A., Meissner, M., Grimm, R., Gerner, C., Sauermann, G., & Foisner, R. (1997): Two-dimensional electrophoresis reveals a nuclear matrix-associated nucleolin complex of basic isoelectric point. Electrophoresis, 18(14): 2645–2653.
Doi: https://doi.org/10.1002/elps.1150181421
[488]
Eger, A., Stockinger, A., Wiche, G., & Foisner, R. (1997): Polarisation-dependent association of plectin with desmoplakin and the lateral submembrane skeleton in MDCK cells. Journal of cell science, 110: 1307-1316.
Prof.(FH) Priv. Doz. Mag. Dr. Andreas Eger
E
Head of Research Institute Krems Bioanalytics / Professor Department...
Prof.(FH) Mag. Dr. Christoph Wiesner
Professor Department of Life Sciences
Institute Biotechnology
Contact
+43 2732 802 276[email protected]
Location
IMC Campus Krems
IMC Campus Trakt G
Core Competencies (3)
Cell and Molecular Biology
Drug Screening
Project management
Active in the degree programmes (2)
Medical and Pharmaceutical Biotechnology
Bachelor of Science in Engineering / full-time
Medical and Pharmaceutical Biotechnology
Master of Science in Engineering / full-time
Projects (6)
Entwicklung einer optogenetisch kontrollierbaren MSC-Zelllinie für die präzise Regulation immunmodulatorischer Faktoren
Project Leader, Department of Life Sciences
Biomarker-basierte therapeutische Prävention von Knochenmetastasen beim Mammakarzinom: die phathophysiologische Rolle der endostalen Nische
Project Leader, Department of Life Sciences
Entwicklung leistungsfähiger Diagnostikverfahren und neuer Therapieansätze in Inflammation und Sepsis
Project Leader, Department of Life Sciences
Nachhaltiges biologisches Recycling von umweltbedenklichen Stoffen (Rare Earth Elements) aus Elektronikabfall und Abwässern
Department of Life Sciences
Testung von rekombinanten polyklonalen Antikörperfragmenten gegen Gluten-Peptide
Department of Life Sciences
Zellbasierte Testsysteme für bioaktive Substanzen
Department of Life Sciences
Publications (26)
[1788]
Hundsberger, H., Stierschneider, A., Sarne, V., Ripper, D., Schimon, J., Weitzenböck, H. P., Schild, D., Jacobi, N., Eger, A., Atzler, J., Klein, C. T., & Wiesner, C. (2021): Concentration-Dependent Pro- and Antitumor Activities of Quercetin in Human Melanoma Spheroids: Comparative Analysis of 2D and 3D Cell Culture Models. Molecules (Basel, Switzerland), 26(3): 717.
Doi: https://doi.org/10.3390/molecules26030717
[1316]
Sarne, V., Huter, S., Braunmueller, S., Rakob, L., Jacobi, N., Kitzwögerer, M., Wiesner, C., Obrist, P., & Seeboeck, R. (2020): Promoter Methylation of Selected Genes in Non-Small-Cell Lung Cancer Patients and Cell Lines. International journal of molecular sciences, 21(13): 4595.
Doi: https://doi.org/10.3390/ijms21134595
[895]
Jacobi, N., Seeboeck, R., Hofmann, E., Schweiger, H., Smolinska, V., Mohr, T., Boyer, A., Sommergruber, W., Lechner, P., Pichler-Huebschmann, C., Önder, K., Hundsberger, H., Wiesner, C., & Eger, A. (2017): Organotypic three-dimensional cancer cell cultures mirror drug responses in vivo: lessons learned from the inhibition of EGFR signaling. Oncotarget, 8(64): 107423–107440.
Doi: https://doi.org/10.18632/oncotarget.22475
[900]
Jacobi, N., Smolinska, V., Seeboeck, R., Stierschneider, A., Klein, C., Hofmann, E., Wiesner, C., Mohr, T., Oender, K., Lechner, P., Kaiser, H., Hundsberger, H., Eger, A. (2017): 3D Anti-Cancer drug discovery models: A promising approach for precision medicine. In IMC Fachhochschule Krems GmbH (Hrsg.), Online-Tagungsband FHK Forschungsforum 2017. Krems: FFH.
[657]
Hundsberger, H., Koppensteiner, A., Hofmann, E., Ripper, D., Pflüger, M., Stadlmann, V., Klein, C. T., Kreiseder, B., Katzlinger, M., Eger, A., Forster, F., Missbichler, A., & Wiesner, C. (2017): A Screening Approach for Identifying Gliadin Neutralizing Antibodies on Epithelial Intestinal Caco-2 Cells. SLAS discovery : advancing life sciences R & D, 22(8): 1035–1043.
Doi: https://doi.org/10.1177/2472555217697435
[1833]
Genov, M., Kreiseder, B., Nagl, M., Wiesner, C. et al. (2016): Tetrahydroanthraquinone Derivative (±)-4-Deoxyaustrocortilutein Induces Cell Cycle Arrest and Apoptosis in Melanoma Cells via Upregulation of p21 and p53 and Downregulation of NF-kappaB. Journal of Cancer, 7(5): 555.
Doi: https://doi:10.7150/jca.13614
[1834]
Preisitsch, M., Niedermeyer, T., Heiden, SE., Neidhardt, I., Kumpfmueller, J., Wurster, M., Harmrolfs, K., Wiesner, C., Enke, H., Mueller, R., Mundt, S. (2016): Cylindrofridins A–C, Linear Cylindrocyclophane-Related Alkylresorcinols from the Cyanobacterium Cylindrospermum stagnale. Journal of natural products, 79(1): 106-115.
Doi: https://doi.org/10.1021/acs.jnatprod.5b00768
[1832]
Preisitsch, M., Heiden, SE., Beerbaum, M., Niedermeyer, T., Schneefeld, M., Herrmann, J., Kumpfmueller, J., Thuermer, A., Neidhardt, I., Wiesner, C., Daniel, R., Mueller, R., Bange, FC., Schmieder, P., Schweder, T., Mundt, S. (2016): Effects of halide ions on the carbamidocyclophane biosynthesis in Nostoc sp. CAVN2. Marine drugs, 14(1): 21.
Doi: https://doi.org/10.3390/md14010021
[1830]
Preisitsch, M., Harmrolfs, K., Pham, HT., Heidern, SE., Fuessl, A., Wiesner, C., Pretsch, A., Switecka-Hagenbruch, M., Niedermeyer, TH., Mueller, R., Mundt, S. (2015): Anti-MRSA-acting carbamidocyclophanes H-L from the Vietnamese cyanobacterium Nostoc sp. CAVN2. The Journal of antibiotics, 68(9): 600-600.
Doi: https://doi.org/10.1038/ja.2015.79
[553]
Kreiseder, B., Holper-Schichl, Y. M., Muellauer, B., Jacobi, N., Pretsch, A., Schmid, J. A., de Martin, R., Hundsberger, H., Eger, A., & Wiesner, C. (2015): Alpha-catulin contributes to drug-resistance of melanoma by activating NF-κB and AP-1. PloS one, 10(3): e0119402.
Doi: https://doi.org/10.1371/journal.pone.0119402
[1831]
Preisitsch, M., Harmrolfs, K., Pham, H., Heiden, SE., Fuessel, A., Wiesner, C., Pretsch, A., et al. (2015): Anti-MRSA-acting carbamidocyclophanes H–L from the Vietnamese cyanobacterium Nostoc sp. CAVN2. The Journal of antibiotics, 68(3): 165-177.
Doi: https://doi.org/10.1038/ja.2014.118
[535]
Pretsch, A., Nagl, M., Schwendinger, K., Kreiseder, B., Wiederstein, M., Pretsch, D., Genov, M., Hollaus, R., Zinssmeister, D., Debbab, A., Hundsberger, H., Eger, A., Proksch, P., & Wiesner, C. (2014): Antimicrobial and anti-inflammatory activities of endophytic fungi Talaromyces wortmannii extracts against acne-inducing bacteria. PloS one, 9(6): e97929.
Doi: https://doi.org/10.1371/journal.pone.0097929
[1829]
Kreiseder, B., Orel, L., Bujnow, C., Buschek, S., Pflueger, M., Schuett, W., Hundsberger, H., de Martin, R., Wiesner, C. (2013): α‐Catulin downregulates E‐cadherin and promotes melanoma progression and invasion. International journal of cancer, 132(3): 521-530.
Doi: https://doi.org/10.1002/ijc.27698
[530]
Pflüger, M., Kapuscik, A., Lucas, R., Koppensteiner, A., Katzlinger, M., Jokela, J., Eger, A., Jacobi, N., Wiesner, C., Hofmann, E., Onder, K., Kopecky, J., Schütt, W., Hundsberger, H. (2013): A combined impedance and AlphaLISA-based approach to identify anti-inflammatory and barrier-protective compounds in human endothelium. Journal of biomolecular screening, 18(1): 67-74.
Doi: https://doi.org/10.1177/1087057112458316
[527]
Amatschek, S., Lucas, R., Eger, A., Pflueger, M., Hundsberger, H., Knoll, C., Grosse-Kracht, S., Schuett, W., Koszik, F., Maurer, D., Wiesner, C. (2011): CXCL9 induces chemotaxis, chemorepulsion and endothelial barrier disruption through CXCR3-mediated activation of melanoma cells. British journal of cancer, 104(3): 469-479.
Doi: https://doi.org/10.1038/sj.bjc.6606056
[601]
Hundsberger, H., Verin, A., Wiesner, C., Pflüger, M., Dulebo, A., Schütt, W., Lasters, I., Männel, D., Wendel, A., Lucas, R. (2008): TNF: a moonlighting protein at the interface between cancer and infection. Frontiers in Bioscience, 13: 5374-86.
Doi: https://doi.org/10.2741/3087
[1828]
Hundsberger, H., Verin, A., Wiesner, C., Pflüger, M., Dulebo, A., Schütt, W., Lasters, I., Männel, D. N., Wendel, A., & Lucas, R. (2008): TNF: a moonlighting protein at the interface between cancer and infection. Frontiers in bioscience : a journal and virtual library, 13: 5374–5386.
Doi: https://doi.org/10.2741/3087
[1826]
Wiesner, C., Pflueger, M., Kopecky, J., Stys, D., Entler, B., Lucas, R., Hundsberger, H., Schuett, W. (2008): Implementation of ECIS technology for the characterization of potential therapeutic drugs that promote wound-healing. GMS Krankenhaushygiene interdisziplinar, 3(1).
[622]
Wiesner, C., Pflüger, M., Kopecky, J., Stys, D., Entler, B., Lucas, R., Hundsberger, H., Schütt, W. (2008): Implementation of ECIS technology for the characterization of potential therapeutic drugs that promote wound-healing. GMS Krankenhaushygiene Interdisziplinär, 3(1): Doc05.
[1827]
Wiesner, C., Winsauer, G., Resch, U. et al. (2008): α-Catulin, a Rho signalling component, can regulate NF-κB through binding to IKK-β, and confers resistance to apoptosis. Oncogene , 27: 2159–2169.
Doi: https://doi.org/10.1038/sj.onc.1210863
[1823]
Wiesner, C., Lucas, R., Pflueger, M., Kleber, C., Kopecky, J., Stys, D., Entler, B., Hundsberger, H., Atzler, J., Hrouzek, P., Lukesova, A., Schuett, W., (2007): Endothelial Cell-Based Methods for the Detection of Cyanobacterial Anti- Inflammatory and Wound-Healing Promoting Metabolites. Drug Metabolism Letters, 1(4): 254-260.
Doi: https://doi.org/10.2174/187231207783221385
[1825]
Winter, D., Moser, J., Kriehuber, E., Wiesner, C., Knobler, R., Trautinger, F., Bombosi, P., Stingl, G., Petzelbauer, P., Rot, A., & Maurer, D. (2007): Down-modulation of CXCR3 surface expression and function in CD8+ T cells from cutaneous T cell lymphoma patients. Journal of immunology, 179(6): 4272-4282.
Doi: https://doi.org/10.4049/jimmunol.179.6.4272
[1822]
Lucas, R., Hundsberger, H., Pflueger, M., Fischer, B., Morel, D., Braun, C., Wendel, A., Chakraborty, T., Schuett, W., Wiesner, C., Hamacher, J. (2007): The Tumor Necrosis Factor-Derived TIP Peptide: A Potential Anti-Edema Drug. Letters in Drug Design & Discovery, 4(5): 336-340.
Doi: https://doi.org/10.2174%2F157018007780867816
[1821]
Hofer-Warbinek, R., Schmid, J.A., Mayer, H., Winsauer, G., Orel, L., Mueller, B., Wiesner, C., Binder, B.R., de Martin, R. (2004): A highly conserved proapoptotic gene, IKIP, located next to the APAF1 gene locus, is regulated by p53. Cell Death & Differentiation, 11(12): 1317 - 1325.
Doi: https://doi.org/10.1038%2Fsj.cdd.4401502
[1820]
Wiesner, C., Hoeth, M., Binder, B.R., de Martin, R. (2002): A functional screening assay for the isolation of transcription factors. Nucleic Acids Research, 30(16): e80.
Doi: https://doi.org/10.1093/nar/gnf079
[1824]
Rohde, D., Wiesner, C., Graf, D. et al. (2000): Interstitial fluid pressure is increased in renal cell carcinoma xenografts. Urological Research, 28: 1-5.
Doi: https://doi.org/10.1007/s002400050001
Prof.(FH) Mag. Dr. Christoph Wiesner
W
Professor Department of Life Sciences
Dr.rer.nat.techn. Georg Sixta
Professor Department of Life Sciences
Institute Biotechnology
Contact
+43 2732 802 351[email protected]
Location
IMC Campus Krems
IMC Campus Trakt G
Active in the degree programmes (3)
Applied Chemistry
Bachelor of Science in Engineering / full-time
Medical and Pharmaceutical Biotechnology
Master of Science in Engineering / full-time
Medical and Pharmaceutical Biotechnology
Bachelor of Science in Engineering / full-time
Dr.rer.nat.techn. Georg Sixta
S
Professor Department of Life Sciences
Prof.(FH) DI Dominik Schild
Professor Department of Life Sciences
Institute Biotechnology
Contact
+43 2732 802 501[email protected]
Location
IMC Campus Krems
IMC Campus Trakt G
Core Competencies (3)
Fermentation development
Biochemical Engineering
Process engineering
Active in the degree programmes (3)
Medical and Pharmaceutical Biotechnology
Bachelor of Science in Engineering / full-time
Applied Chemistry
Bachelor of Science in Engineering / full-time
Medical and Pharmaceutical Biotechnology
Master of Science in Engineering / full-time
Projects (5)
Nachhaltiges biologisches Recycling von umweltbedenklichen Stoffen (Rare Earth Elements) aus Elektronikabfall und Abwässern
Project Leader, Department of Life Sciences
Synthese und industrielle Verwendung von Hydroxytyrosol
Project Leader, Department of Life Sciences
Extremophiles
Department of Life Sciences
Co-Kultivierung von Mikroorganismen
Project Leader, Department of Life Sciences
Zellbasierte Testsysteme für bioaktive Substanzen
Department of Life Sciences
Publications (2)
[1788]
Hundsberger, H., Stierschneider, A., Sarne, V., Ripper, D., Schimon, J., Weitzenböck, H. P., Schild, D., Jacobi, N., Eger, A., Atzler, J., Klein, C. T., & Wiesner, C. (2021): Concentration-Dependent Pro- and Antitumor Activities of Quercetin in Human Melanoma Spheroids: Comparative Analysis of 2D and 3D Cell Culture Models. Molecules (Basel, Switzerland), 26(3): 717.
Doi: https://doi.org/10.3390/molecules26030717
[1110]
Amer, H., Mimini, V., Schild, D., Rinner, U., Bacher, H., Potthast, A., Rosenau, T. (2019): Gram-scale economical synthesis of trans-coniferyl alcohol and its corresponding thiol. Holzforschung, 74(2): 197-202.
Doi: https://doi.org/10.1515/hf-2018-0297
Prof.(FH) DI Dominik Schild
S
Professor Department of Life Sciences
Dipl.Biol. Maren Pflüger, PhD
Research Assistant / Department of Life Sciences
Institute Biotechnology
Contact
+43 2732 802 529[email protected]
Location
IMC Campus Krems
IMC Campus Trakt D
Core Competencies (3)
Inflammation
Cytotoxicity
Wound healing
Active in the degree programmes (1)
Medical and Pharmaceutical Biotechnology
Bachelor of Science in Engineering / full-time
Projects (4)
Extremophiles
Department of Life Sciences
Etablierung innovativer humaner Tumor-Mimetika für das Screening von bioaktiven Wirkstoffen
Department of Life Sciences
Biopharm - Isolation bioaktiver Stoffe aus Cyanobakterien
Department of Life Sciences
Zellbasierte Testsysteme für bioaktive Substanzen
Department of Life Sciences
Publications (14)
[657]
Hundsberger, H., Koppensteiner, A., Hofmann, E., Ripper, D., Pflüger, M., Stadlmann, V., Klein, C. T., Kreiseder, B., Katzlinger, M., Eger, A., Forster, F., Missbichler, A., & Wiesner, C. (2017): A Screening Approach for Identifying Gliadin Neutralizing Antibodies on Epithelial Intestinal Caco-2 Cells. SLAS discovery : advancing life sciences R & D, 22(8): 1035–1043.
Doi: https://doi.org/10.1177/2472555217697435
[579]
Al-Harthy, T., Zoghaib, W. M., Pflüger, M., Schöpel, M., Önder, K., Reitsammer, M., Hundsberger, H., Stoll, R., & Abdel-Jalil, R. (2016): Design, Synthesis, and Cytotoxicity of 5-Fluoro-2-methyl-6-(4-aryl-piperazin-1-yl) Benzoxazoles. Molecules, 21(10): 1290.
Doi: https://doi.org/10.3390/molecules21101290
[473]
Al-Harthy, T., Abdel-Jalil, R., Zoghaib, W., Pflüger, M., Hofmann, E., & Hundsberger, H. (2016): Design and synthesis of benzothiazole schiff bases of potential antitumor activity. Heterocycles, 92(7): 1282-1292.
Doi: https://doi.org/10.3987/COM-16-13471
[534]
Kapuścik, A., Hrouzek, P., Kuzma, M., Bártová, S., Novák, P., Jokela, J., Pflüger, M., Eger, A., Hundsberger, H., Kopecký, J. (2013): Novel Aeruginosin-865 from Nostoc sp. as a potent anti-inflammatory agent. Chembiochem : a European journal of chemical biology, 14(17): 2329-2337.
Doi: https://doi.org/10.1002/cbic.201300246
[1829]
Kreiseder, B., Orel, L., Bujnow, C., Buschek, S., Pflueger, M., Schuett, W., Hundsberger, H., de Martin, R., Wiesner, C. (2013): α‐Catulin downregulates E‐cadherin and promotes melanoma progression and invasion. International journal of cancer, 132(3): 521-530.
Doi: https://doi.org/10.1002/ijc.27698
[530]
Pflüger, M., Kapuscik, A., Lucas, R., Koppensteiner, A., Katzlinger, M., Jokela, J., Eger, A., Jacobi, N., Wiesner, C., Hofmann, E., Onder, K., Kopecky, J., Schütt, W., Hundsberger, H. (2013): A combined impedance and AlphaLISA-based approach to identify anti-inflammatory and barrier-protective compounds in human endothelium. Journal of biomolecular screening, 18(1): 67-74.
Doi: https://doi.org/10.1177/1087057112458316
[621]
Khare, V., Lyakhovich, A., Dammann, K., Lang, M., Borgmann, M., Tichy, B., Pospisilova, S., Luciani, G., Campregher, C., Evstatiev, R., Pflueger, M., Hundsberger, H., & Gasche, C. (2013): Mesalamine modulates intercellular adhesion through inhibition of p-21 activated kinase-1. Biochemical Pharmacology, 85(2): 234-244.
Doi: https://doi.org/10.1016/j.bcp.2012.10.026
[527]
Amatschek, S., Lucas, R., Eger, A., Pflueger, M., Hundsberger, H., Knoll, C., Grosse-Kracht, S., Schuett, W., Koszik, F., Maurer, D., Wiesner, C. (2011): CXCL9 induces chemotaxis, chemorepulsion and endothelial barrier disruption through CXCR3-mediated activation of melanoma cells. British journal of cancer, 104(3): 469-479.
Doi: https://doi.org/10.1038/sj.bjc.6606056
[601]
Hundsberger, H., Verin, A., Wiesner, C., Pflüger, M., Dulebo, A., Schütt, W., Lasters, I., Männel, D., Wendel, A., Lucas, R. (2008): TNF: a moonlighting protein at the interface between cancer and infection. Frontiers in Bioscience, 13: 5374-86.
Doi: https://doi.org/10.2741/3087
[1828]
Hundsberger, H., Verin, A., Wiesner, C., Pflüger, M., Dulebo, A., Schütt, W., Lasters, I., Männel, D. N., Wendel, A., & Lucas, R. (2008): TNF: a moonlighting protein at the interface between cancer and infection. Frontiers in bioscience : a journal and virtual library, 13: 5374–5386.
Doi: https://doi.org/10.2741/3087
[1826]
Wiesner, C., Pflueger, M., Kopecky, J., Stys, D., Entler, B., Lucas, R., Hundsberger, H., Schuett, W. (2008): Implementation of ECIS technology for the characterization of potential therapeutic drugs that promote wound-healing. GMS Krankenhaushygiene interdisziplinar, 3(1).
[622]
Wiesner, C., Pflüger, M., Kopecky, J., Stys, D., Entler, B., Lucas, R., Hundsberger, H., Schütt, W. (2008): Implementation of ECIS technology for the characterization of potential therapeutic drugs that promote wound-healing. GMS Krankenhaushygiene Interdisziplinär, 3(1): Doc05.
[1823]
Wiesner, C., Lucas, R., Pflueger, M., Kleber, C., Kopecky, J., Stys, D., Entler, B., Hundsberger, H., Atzler, J., Hrouzek, P., Lukesova, A., Schuett, W., (2007): Endothelial Cell-Based Methods for the Detection of Cyanobacterial Anti- Inflammatory and Wound-Healing Promoting Metabolites. Drug Metabolism Letters, 1(4): 254-260.
Doi: https://doi.org/10.2174/187231207783221385
[1822]
Lucas, R., Hundsberger, H., Pflueger, M., Fischer, B., Morel, D., Braun, C., Wendel, A., Chakraborty, T., Schuett, W., Wiesner, C., Hamacher, J. (2007): The Tumor Necrosis Factor-Derived TIP Peptide: A Potential Anti-Edema Drug. Letters in Drug Design & Discovery, 4(5): 336-340.
Doi: https://doi.org/10.2174%2F157018007780867816
Dipl.Biol. Maren Pflüger, PhD
P
Research Assistant / Department of Life Sciences
Prof.(FH) Mag. Dana Mezricky
Professorin Department of Life Sciences
Institute Biotechnology
Contact
+43 2732 802 322[email protected]
Location
IMC Campus Krems
IMC Campus Trakt G
Core Competencies (3)
GMP/GLP
Molecular Biology
Proteinchemistry / Immunology/ Biochemical Analytics Methods
Active in the degree programmes (2)
Medical and Pharmaceutical Biotechnology
Bachelor of Science in Engineering / full-time
Medical and Pharmaceutical Biotechnology
Master of Science in Engineering / full-time
Projects (3)
Nachhaltiges biologisches Recycling von umweltbedenklichen Stoffen (Rare Earth Elements) aus Elektronikabfall und Abwässern
Department of Life Sciences
Extremophiles
Department of Life Sciences
Co-Kultivierung von Mikroorganismen
Department of Life Sciences
Publications (4)
[1329]
Čížková, M., Mezricky, P., Mezricky, D., Rucki, M., Zachleder, V., Vítová, M. (2020): Bioaccumulation of Rare Earth Elements from Waste Luminophores in the Red Algae, Galdieria phlegrea. Waste Biomass Valor.
Doi: https://doi.org/10.1007/s12649-020-01182-3
[1328]
Rezanka, T., Rezanka, M., Mezricky, D., Vítova, M. (2020): Lipidomic analysis of diatoms cultivated with silica nanoparticles. Phytochemistry, 177: 112452.
Doi: https://doi.org/10.1016/j.phytochem.2020.112452
[1020]
Čížková, M., Mezricky, D., Rucki, M., Tóth, T. M., Náhlík, V., Lanta, V., Bišová, K., Zachleder, V., & Vítová, M. (2019): Bio-mining of Lanthanides from Red Mud by Green Microalgae. Molecules , 24(7): 1356.
Doi: https://doi.org/10.3390/molecules24071356
[352]
Řezanka, T., Kaineder, K., Mezricky, D., Řezanka, M., Bišová, K., Zachleder, V., & Vítová, M. (2016): The effect of lanthanides on photosynthesis, growth, and chlorophyll profile of the green alga Desmodesmus quadricauda. Photosynthesis Research, 130(1-3): 335-346.
Doi: https://doi.org/10.1007/s11120-016-0263-9
Prof.(FH) Mag. Dana Mezricky
M
Professorin Department of Life Sciences
DI (FH) Anita Koppensteiner
Research Assistant / Department of Life Sciences
Institute Biotechnology
Contact
+43 2732 802 527[email protected]
Location
IMC Campus Krems
IMC Campus Trakt D
Core Competencies (3)
Protein Production, Purification and Analysis
Cell-Based Assays/Microscopy
Biochemical Test Methods and Analysis
Active in the degree programmes (3)
Medical and Pharmaceutical Biotechnology
Bachelor of Science in Engineering / full-time
Applied Chemistry
Bachelor of Science in Engineering / full-time
Medical and Pharmaceutical Biotechnology
Master of Science in Engineering / full-time
Projects (6)
Nachhaltiges biologisches Recycling von umweltbedenklichen Stoffen (Rare Earth Elements) aus Elektronikabfall und Abwässern
Department of Life Sciences
Die Rolle von NFR2 in der Melanomprogression - Einblicke in die Mechanismen von Metastasen
Department of Life Sciences
Extremophiles
Department of Life Sciences
MEMESA – Metastasierendes Melanom Spezifische Antikörper
Department of Life Sciences
AdsorbTech: Entwicklung einer neuen Technologieplattform für Peptid-basierte therapeutische Apheresesysteme
Department of Life Sciences
Etablierung innovativer, vaskulärer Äquivalente zur Entwicklung von Detektionsmodulen für Hochdurchsatz-Verfahren und zur Entwicklung von anti-entzündlichen Peptiden
Department of Life Sciences
Publications (3)
[657]
Hundsberger, H., Koppensteiner, A., Hofmann, E., Ripper, D., Pflüger, M., Stadlmann, V., Klein, C. T., Kreiseder, B., Katzlinger, M., Eger, A., Forster, F., Missbichler, A., & Wiesner, C. (2017): A Screening Approach for Identifying Gliadin Neutralizing Antibodies on Epithelial Intestinal Caco-2 Cells. SLAS discovery : advancing life sciences R & D, 22(8): 1035–1043.
Doi: https://doi.org/10.1177/2472555217697435
[600]
Schütz, B., Koppensteiner, A., Schörghofer, D., Kinslechner, K., Timelthaler, G., Eferl, R., Hengstschläger, M., Missbichler, A., Hundsberger, H., & Mikula, M. (2016): Generation of metastatic melanoma specific antibodies by affinity purification. Scientific reports, 6: 37253.
Doi: https://doi.org/10.1038/srep37253
[530]
Pflüger, M., Kapuscik, A., Lucas, R., Koppensteiner, A., Katzlinger, M., Jokela, J., Eger, A., Jacobi, N., Wiesner, C., Hofmann, E., Onder, K., Kopecky, J., Schütt, W., Hundsberger, H. (2013): A combined impedance and AlphaLISA-based approach to identify anti-inflammatory and barrier-protective compounds in human endothelium. Journal of biomolecular screening, 18(1): 67-74.
Doi: https://doi.org/10.1177/1087057112458316
DI (FH) Anita Koppensteiner
K
Research Assistant / Department of Life Sciences
Prof.(FH) Priv.Doz. Dr. Reinhard Klein
Professor Department of Life Sciences
Institute Biotechnology
Contact
+43 2732 802 883[email protected]
Location
IMC Campus Krems
IMC Campus Trakt G
Core Competencies (2)
Virology
Molecular biology
Active in the degree programmes (2)
Medical and Pharmaceutical Biotechnology
Bachelor of Science in Engineering / full-time
Medical and Pharmaceutical Biotechnology
Master of Science in Engineering / full-time
Projects (3)
In-Vivo-RNA Interferenzstrategien gegen Adenoviren
Project Leader, Department of Life Sciences
Virale und fungale Infektionen
Project Leader, Department of Life Sciences
RNA Interferenz als Methode zur Inhibierung von Virusinfektionen
Project Leader, Department of Life Sciences
Publications (25)
[1639]
Selb, R., Derntl, C., Klein, R., Alte, B., Hofbauer, C., Kaufmann, M., Beraha, J., Schöner, L., & Witte, A. (2017): The Viral Gene ORF79 Encodes a Repressor Regulating Induction of the Lytic Life Cycle in the Haloalkaliphilic Virus ϕCh1. Journal of virology, 91(9): e00206-17.
Doi: https://doi.org/10.1128/JVI.00206-17
[353]
Derntl, C., Selb, R., Klein, R., Alte, B., & Witte, A. (2015): Genomic manipulations in alkaliphilic haloarchaea demonstrated by a gene disruption in Natrialba magadii. FEMS microbiology letters, 362(21): fnv179.
Doi: https://doi.org/10.1093/femsle/fnv179
[1648]
Derntl, C., Selb, R., Klein, R., Alte, B., & Witte, A. (2015): Genomic manipulations in alkaliphilic haloarchaea demonstrated by a gene disruption in Natrialba magadii. FEMS microbiology letters, 362(21): fnv179.
Doi: https://doi.org/10.1093/femsle/fnv179
[355]
Bellutti, F., Kauer, M., Kneidinger, D., Lion, T., & Klein, R. (2015): Identification of RISC-associated adenoviral microRNAs, a subset of their direct targets, and global changes in the targetome upon lytic adenovirus 5 infection. Journal of virology, 89(3): 1608–1627.
Doi: https://doi.org/10.1128/JVI.02336-14
[1649]
Bellutti, F., Kauer, M., Kneidinger, D., Lion, T., & Klein, R. (2015): Identification of RISC-associated adenoviral microRNAs, a subset of their direct targets, and global changes in the targetome upon lytic adenovirus 5 infection. Journal of virology, 89(3): 1608–1627.
Doi: https://doi.org/10.1128/JVI.02336-14
[1650]
Ibrišimović, M., Lion, T., & Klein, R. (2013): Combinatorial targeting of 2 different steps in adenoviral DNA replication by herpes simplex virus thymidine kinase and artificial microRNA expression for the inhibition of virus multiplication in the presence of ganciclovir. BMC biotechnology, 13(1): 54.
Doi: https://doi.org/10.1186/1472-6750-13-54
[1652]
Mayrhofer-Iro, M., Ladurner, A., Meissner, C., Derntl, C., Reiter, M., Haider, F., Dimmel, K., Rössler, N., Klein, R., Baranyi, U., Scholz, H., & Witte, A. (2013): Utilization of virus φCh1 elements to establish a shuttle vector system for Halo(alkali)philic Archaea via transformation of Natrialba magadii. Applied and environmental microbiology, 79(8): 2741–2748.
Doi: https://doi.org/10.1128/AEM.03287-12
[1651]
Ibrišimović, M., Kneidinger, D., Lion, T., & Klein, R. (2013): An adenoviral vector-based expression and delivery system for the inhibition of wild-type adenovirus replication by artificial microRNAs. Antiviral research, 97(1): 10–23.
Doi: https://doi.org/10.1016/j.antiviral.2012.10.008
[1653]
Kneidinger, D., Ibrišimović, M., Lion, T., & Klein, R. (2012): Inhibition of adenovirus multiplication by short interfering RNAs directly or indirectly targeting the viral DNA replication machinery. Antiviral research, 94(3): 195–207.
Doi: https://doi.org/10.1016/j.antiviral.2012.03.011
[1654]
Ibrišimović, M., Nagl, U., Kneidinger, D., Rauch, M., Lion, T., & Klein, R. (2012): Targeted expression of herpes simplex virus thymidine kinase in adenovirus-infected cells reduces virus titers upon treatment with ganciclovir in vitro. The journal of gene medicine, 114(1): 3–19.
Doi: https://doi.org/10.1002/jgm.1638
[1655]
Klein, R., Rössler, N., Iro, M., Scholz, H., & Witte, A. (2012): Haloarchaeal myovirus φCh1 harbours a phase variation system for the production of protein variants with distinct cell surface adhesion specificities. Molecular microbiology, 83(1): 137–150.
Doi: https://doi.org/10.1111/j.1365-2958.2011.07921.x
[1656]
Klein, R., Ruttkowski, B., Schwab, S., Peterbauer, T., Salmons, B., Günzburg, W. H., & Hohenadl, C. (2008): Mouse mammary tumor virus promoter-containing retroviral promoter conversion vectors for gene-directed enzyme prodrug therapy are functional in vitro and in vivo. Journal of biomedicine & biotechnology, 2008(683505 ): 10.
Doi: https://doi.org/10.1155/2008/683505
[1657]
Agu, C. A., Klein, R., Lengler, J., Schilcher, F., Gregor, W., Peterbauer, T., Bläsi, U., Salmons, B., Günzburg, W. H., & Hohenadl, C. (2007): Bacteriophage-encoded toxins: the lambda-holin protein causes caspase-independent non-apoptotic cell death of eukaryotic cells. Cellular microbiology, 9(7): 1753–1765.
Doi: https://doi.org/10.1111/j.1462-5822.2007.00911.x
[1658]
Iro, M., Klein, R., Gálos, B., Baranyi, U., Rössler, N., & Witte, A. (2007): The lysogenic region of virus phiCh1: identification of a repressor-operator system and determination of its activity in halophilic Archaea. xtremophiles : life under extreme conditions, 11(2): 383–396.
Doi: https://doi.org/10.1007/s00792-006-0040-3
[1660]
Klein, R., Ruttkowski, B., Knapp, E., Salmons, B., Günzburg, W. H., & Hohenadl, C. (2006): WPRE-mediated enhancement of gene expression is promoter and cell line specific. Gene, 372: 153–161.
Doi: https://doi.org/10.1016/j.gene.2005.12.018
[1661]
Hand, N. J., Klein, R., Laskewitz, A., & Pohlschröder, M. (2006): Archaeal and bacterial SecD and SecF homologs exhibit striking structural and functional conservation. Journal of bacteriology,, 188(4): 1251–1259.
Doi: https://doi.org/10.1128/JB.188.4.1251-1259.2006
[1659]
Agu, C. A., Klein, R., Schwab, S., König-Schuster, M., Kodajova, P., Ausserlechner, M., Binishofer, B., Bläsi, U., Salmons, B., Günzburg, W. H., & Hohenadl, C. (2006): The cytotoxic activity of the bacteriophage lambda-holin protein reduces tumour growth rates in mammary cancer cell xenograft models. The journal of gene medicine, 8(2): 229–241.
Doi: https://doi.org/10.1002/jgm.833
[1662]
Mangold, M., Siller, M., Roppenser, B., Vlaminckx, B. J., Penfound, T. A., Klein, R., Novak, R., Novick, R. P., & Charpentier, E. (2004): Synthesis of group A streptococcal virulence factors is controlled by a regulatory RNA molecule. Molecular microbiology, 53(5): 1515–1527.
Doi: https://doi.org/10.1111/j.1365-2958.2004.04222.x
[1663]
Rössler, N., Klein, R., Scholz, H., & Witte, A. (2004): Inversion within the genome of the haloalkaliphilic virus phiCh1 results in differential expression of structural proteins. Molecular microbiology, 52(2): 413–426.
Doi: https://doi.org/10.1111/j.1365-2958.2003.03983.x
[1664]
Klein, R., Baranyi, U., Rössler, N., Greineder, B., Scholz, H., & Witte, A. (2002): Natrialba magadii virus fCh: First complete nucleotide sequence and functional organization of a virus infecting an extreme haloalkaliphilic archaeon. Molecular microbiology, 45(3): 851–863.
Doi: https://doi.org/10.1046/j.1365-2958.2002.03064.x
[1666]
Klein, R., Greineder, B., Baranyi, U., & Witte, A. (2000): The structural protein E of the archaeal virus phiCh1: evidence for processing in Natrialba magadii during virus maturation. Virology, 276(2): 376–387.
Doi: https://doi.org/10.1006/viro.2000.0565
[1665]
Baranyi, U., Klein, R., Lubitz, W., Krüger, D. H., & Witte, A. (2000): The archaeal halophilic virus-encoded Dam-like methyltransferase M. phiCh1-I methylates adenine residues and complements dam mutants in the low salt environment of Escherichia coli. Molecular microbiology, 35(5): 1168–1179.
Doi: https://doi.org/10.1046/j.1365-2958.2000.01786.x
[1667]
Katinger, A., Lubitz, W., Szostak, M. P., Stadler, M., Klein, R., Indra, A., Huter, V., & Hensel, A. (1999): Pigs aerogenously immunized with genetically inactivated (ghosts) or irradiated Actinobacillus pleuropneumoniae are protected against a homologous aerosol challenge despite differing in pulmonary cellular and antibody responses. Journal of biotechnology, 73(2-3): 251–260.
Doi: https://doi.org/10.1016/s0168-1656(99)00143-1
[1668]
Witte, A., Baranyi, U., Klein, R., Sulzner, M., Luo, C., Wanner, G., Krüger, D. H., & Lubitz, W. (1997): Characterization of Natronobacterium magadii phage phi Ch1, a unique archaeal phage containing DNA and RNA. Molecular microbiology, 23(3): 603–616.
Doi: https://doi.org/10.1046/j.1365-2958.1997.d01-1879.x
[1669]
Szostak, M. P., Hensel, A., Eko, F. O., Klein, R., Auer, T., Mader, H., Haslberger, A., Bunka, S., Wanner, G., & Lubitz, W. (1996): Bacterial ghosts: non-living candidate vaccines. Journal of biotechnology, 44(1-3): 161–170.
Doi: https://doi.org/10.1016/0168-1656(95)00123-9
Prof.(FH) Priv.Doz. Dr. Reinhard Klein
K
Professor Department of Life Sciences
Prof.(FH) Dr. Christian Klein
Professor Department of Life Sciences
Institute Biotechnology
Contact
+43 2732 802 522[email protected]
Location
IMC Campus Krems
IMC Campus Trakt G
Core Competencies (3)
Computer-Aided Drug Design
Biochemical Systems Theory
Molecular Modeling and Chemoinformatics
Active in the degree programmes (3)
Medical and Pharmaceutical Biotechnology
Bachelor of Science in Engineering / full-time
Applied Chemistry
Bachelor of Science in Engineering / full-time
Medical and Pharmaceutical Biotechnology
Master of Science in Engineering / full-time
Projects (4)
Entwicklung von therapeutischen Peptiden für Krebs- und regenerative Medizin
Department of Life Sciences
Entwicklung einer Design-Pipeline für innovative Protein-Protein-Interaktionshemmer
Project Leader, Department of Life Sciences
Entwicklung neuer immunregulierender Peptide und geschlechtsspezifischer organotypischer Zellmodelle für humane Sepsis
Department of Life Sciences
Funktionale Validierung prädiktiver Biomarker für zielgerichtete Krebstherapien
Department of Life Sciences
Publications (30)
[1788]
Hundsberger, H., Stierschneider, A., Sarne, V., Ripper, D., Schimon, J., Weitzenböck, H. P., Schild, D., Jacobi, N., Eger, A., Atzler, J., Klein, C. T., & Wiesner, C. (2021): Concentration-Dependent Pro- and Antitumor Activities of Quercetin in Human Melanoma Spheroids: Comparative Analysis of 2D and 3D Cell Culture Models. Molecules (Basel, Switzerland), 26(3): 717.
Doi: https://doi.org/10.3390/molecules26030717
[1315]
Ablinger, C., Geisler, S. M., Stanika, R. I., Klein, C. T., & Obermair, G. J. (2020): Neuronal α2δ proteins and brain disorders. Pflugers Archiv : European journal of physiology, 472(7): 845-863.
Doi: https://doi.org/10.1007/s00424-020-02420-2
[900]
Jacobi, N., Smolinska, V., Seeboeck, R., Stierschneider, A., Klein, C., Hofmann, E., Wiesner, C., Mohr, T., Oender, K., Lechner, P., Kaiser, H., Hundsberger, H., Eger, A. (2017): 3D Anti-Cancer drug discovery models: A promising approach for precision medicine. In IMC Fachhochschule Krems GmbH (Hrsg.), Online-Tagungsband FHK Forschungsforum 2017. Krems: FFH.
[657]
Hundsberger, H., Koppensteiner, A., Hofmann, E., Ripper, D., Pflüger, M., Stadlmann, V., Klein, C. T., Kreiseder, B., Katzlinger, M., Eger, A., Forster, F., Missbichler, A., & Wiesner, C. (2017): A Screening Approach for Identifying Gliadin Neutralizing Antibodies on Epithelial Intestinal Caco-2 Cells. SLAS discovery : advancing life sciences R & D, 22(8): 1035–1043.
Doi: https://doi.org/10.1177/2472555217697435
[879]
Volk, K., Breunig, S. D., Rid, R., Herzog, J., Bräuer, M., Hundsberger, H., Klein, C., Müller, N., & Önder, K. (2017): Structural analysis and interaction studies of acyl-carrier protein (acpP) of Staphylococcus aureus, an extraordinarily thermally stable protein. Biological chemistry, 398(1): 125-133.
Doi: https://doi.org/10.1515/hsz-2016-0185
[359]
Hofmann, E., Seeboeck, R., Jacobi, N., Obrist, P., Huter, S., Klein, C., Oender, K., Wiesner, C., Hundsberger, H., & Eger, A. (2016): The combinatorial approach of laser-captured microdissection and reverse transcription quantitative polymerase chain reaction accurately determines HER2 status in breast cancer. Biomarker research, 7(4): 8.
Doi: https://doi.org/10.1186/s40364-016-0062-7
[557]
Jacobi, N., Smolinska, V., Stierschneider, A., Klein, C., Oender, K., Lechner, P., Kaiser, H., Hundsberger, H., Eger, A. (2016): Development of organotypic cancer models for the identification of individualized cancer therapies. In FH des BFI Wien (Hrsg.), Online-Tagungsband FHK Forschungsforum 2016. Wien: FFH.
[1819]
Solca, F., Dahl, G., Zoephel, A., Bader, G., Sanderson, M., Klein, C.T., Kraemer, O., Himmelsbach, F., Haaksma, E., Adolf, G. R. (2012): Target Binding Properties and Cellular Activity of Afatinib (BIBW 2992), an Irreversible ErbB Family Blocker. Journal of Pharmacology and Experimental Therapeutics, 343(2): 342-350.
Doi: https://doi.org/10.1124/jpet.112.197756
[1818]
Klein, C.T., Kaiser, D., Ecker, G. (2004): 3D Topolgical Distance-Based Descriptors for Use in QSAR and Diversity Analysis. Journal of Chemical Information and Computer Sciences, 44(1): 200-209.
Doi: https://doi.org/10.1021/ci0256236
[1817]
Klein, C.T., Kaiser, D., Kopp, S., Chiba, P., Ecker, G. (2002): Similarity-Based SAR as Tool for Early ADME Profiling. Journal of Computer-Aided Molecular Design, 16: 785-793.
Doi: https://doi.org/10.1023/A:1023828527638
[1816]
Klein, C.T., Kaiblinger, N., Wolschann, P. (2002): Internally Defined Distances in 3D-Quantitative Structure-Activity Relationships. Journal of Computer-Aided Molecular Design, 16: 79-93.
Doi: https://doi.org/10.1023/A:1016308417830
[1812]
Mayer, B., Klein, C.T. (2000): Influence of Solvation on the Helix Forming Tendency of Nonpolar Amino Acids. Journal of Molecular Structure: THEOCHEM, 532(1-3): 213-226.
Doi: https://doi.org/10.1016/S0166-1280(00)00559-5
[1815]
Buchbauer, G., Klein, C.T., Wailzer, B., Wolschann, P. (2000): Threshold-Based Structure-Activity Relationships of Pyrazines with Bell Pepper Flavor. Journal of Agricultural and Food Chemistry, 48(9): 4273-4278.
Doi: https://doi.org/10.1021/jf000192h
[1809]
Klein, C.T., Polheim, D., Viernstein, H., Wolschann, P. (2000): A Method for Estimation of the Free Energies of Complexation between ß-Cyclodextrin and Guest Molecules. Journal of Inclusion Phenomena, 36(4): 409-423.
Doi: https://doi.org/10.1023/A:1008063412529
[1813]
Klein, C.T., Pircher, H., Wailzer, B., Buchbauer, G., Wolschann, P. (2000): Quantitative Structure-Property Study on Pyrazines with Bell Peper Flavor. Scientific Pharmaceutica, 68(1): 41-56.
Doi: https://doi.org/10.3797/scipharm.aut-00-04
[1811]
Klein, C.T., Lawtrakul, L., Hannongbua, S., Wolschann, P. (2000): Accessible Charges as Sensitive Descriptors in Structure-Activity Relationships. A Study on HEPT-based HIV-1 RT Inhibitors. Scientific Pharmaceutica, 68(1): 25-40.
Doi: https://doi.org/10.3797/scipharm.aut-00-03
[1814]
Klein, C.T., Viernstein, H., Wolschann, P. (2000): Free Energy Prediction of Complexation between ß-Cyclodextrin and Guest Molecules: External Predictivity of MR and PLS Models. Scientific Pharamaceutica, 68(1): 15-24.
Doi: https://doi.org/10.3797/scipharm.aut-00-02
[1810]
Klein, C.T., Polheim, D., Viernstein, H., Wolschann, P. (2000): Predicting the Free Energies of Complexation between Cyclodextrins and Guest Molecules: Linear versus Nonlinear Models. Pharamaceutical Research, 17: 358-365.
Doi: https://doi.org/10.1023/A:1007565409407
[1808]
Mayer, B., Klein, C.T., Köhler, G. (1999): Selective Assembly of Cyclodextrins on Poly(ethylene oxide) Poly(propylene oxide) Copolymers. Journal of Computer-Aided Molecular Design, 13: 373-383.
Doi: https://doi.org/10.1023/A:1008095501870
[1807]
Klein, C.T., Mayer, B. (1999): Sources for Switches and Structure Formation in Metabolic Pathways. Biosystems, 51(1): 41-52.
Doi: https://doi.org/10.1016/S0303-2647(99)00012-X
[1805]
Klein, C.T., Mayer, B., Köhler, G., Wolschann, P. (1998): Systematic Stepsize Variation: An Efficient Method for Searching the Conformational Space of Polypeptides. Journal of Computational Chemistry, 19(13): 1470-1481.
Doi: https://doi.org/10.1002/(SICI)1096-987X(199810)19:13<1470::AID-JCC4>3.0.CO;2-N
[1806]
Klein, C.T. (1998): Hysteresis-Driven Pattern Formation in Biochemical Networks. Journal of Theoretical Biology, 194(2): 263-274.
Doi: https://doi.org/10.1006/jtbi.1998.0757
[1804]
Mayer, B., Marconi, G., Klein, C.T., Köhler, G., Wolschann, P. (1997): Structural Analysis of Host–Guest Systems. Methyl-substituted Phenols in beta;-Cyclodextrin. Journal of inclusion phenomena and molecular recognition in chemistry, 29: 79-93.
Doi: https://doi.org/10.1023/A:1007920606983
[1802]
Klein, C.T., Mayer, B. (1997): A Model for Pattern Formation in Gap-Junction Coupled Cells. Journal of Theoretical Biology, 186(1): 107-115.
Doi: https://doi.org/10.1006/jtbi.1996.0337
[1803]
Grabner, G., Monti, S., Marconi, G., Mayer, B., Klein, C.T., Köhler, G. (1997): Spectroscopic and Photochemical Study of Inclusion Complexes of Dimethoxybenzenes with Cyclodextrins. The Journal of Physical Chemistry , 100(51): 20068-20075.
Doi: https://doi.org/10.1021/jp962231r
[1799]
Marconi, G., Mayer, B., Klein, C.T., Köhler, G. (1996): The structure of higher order C60-fullerene-γ-cyclodextrin complexes. Chemical Physics Letters, 260(5-6): 589-594.
Doi: https://doi.org/10.1016/0009-2614(96)00915-3
[1801]
Köhler, G., Grabner, G., Klein, C.T., Marconi, G., Mayer, B., Monti, S., Rechthaler, K., Rotkiewicz, K., Viernstein, H., Wolschann, P. (1996): Structure and spectroscopic Properties in Cyclodextrin Inclusion Complexes. In Szejtli, J., Szente, L. (Hrsg.), Proceedings of the Eighth International Symposium on Cyclodextrins (215-220). Budapest, Hungary: Springer, Dordrecht.
Doi: https://doi.org/10.1007/978-94-011-5448-2_46
[1800]
Klein, C.T., Mayer, B., Köhler, G., Wolschann, P. (1996): Influence of solvation on helix formation of poly-alanine studied by multiple annealing simulations. Journal of Molecular Structure: THEOCHEM, 372(1): 33-43.
Doi: https://doi.org/10.1016/S0166-1280(96)04745-8
[1796]
Klein, C. T., & Seelig, F. F. (1995): Turing structures in a system with regulated gap-junctions. Bio Systems, 35(1): 15–23.
Doi: https://doi.org/10.1016/0303-2647(94)01478-p
[1797]
Klein, C.T., Mayer, B., Köhler, G., Mraz, K., Reiter, S., Viernstein, H., Wolschann, P. (1995): Solubility and Molecular Modeling of Triflumizole-ß-cyclodextrin Inclusion Complexes. Journal of inclusion phenomena and molecular recognition in chemistry, 22: 15–32.
Doi: https://doi.org/10.1007/BF00706495
Prof.(FH) Dr. Christian Klein
K
Professor Department of Life Sciences
Prof.(FH) DI Bernhard Klausgraber
Professor Department of Life Sciences
Institute Biotechnology
Contact
+43 2732 802 348[email protected]
Location
IMC Campus Krems
IMC Campus Trakt G
Core Competencies (3)
Inorganic and Organic Chemistry
Microbiology
Fermentation Development and Optimization
Active in the degree programmes (2)
Medical and Pharmaceutical Biotechnology
Bachelor of Science in Engineering / full-time
Medical and Pharmaceutical Biotechnology
Master of Science in Engineering / full-time
Projects (5)
Nachhaltiges biologisches Recycling von umweltbedenklichen Stoffen (Rare Earth Elements) aus Elektronikabfall und Abwässern
Department of Life Sciences
Synthese und industrielle Verwendung von Hydroxytyrosol
Department of Life Sciences
Extremophiles
Project Leader, Department of Life Sciences
Co-Kultivierung von Mikroorganismen
Department of Life Sciences
Etablierung innovativer humaner Tumor-Mimetika für das Screening von bioaktiven Wirkstoffen
Department of Life Sciences
Prof.(FH) DI Bernhard Klausgraber
K
Professor Department of Life Sciences
Prof.(FH) Dr. Barbara Entler
Professor Department of Life Sciences
Institute Biotechnology
Contact
+43 2732 802 361[email protected]
Location
IMC Campus Krems
IMC Campus Trakt G
Core Competencies (3)
Microbiology
Microbial Monitoring
Genetic Engineering
Active in the degree programmes (2)
Medical and Pharmaceutical Biotechnology
Bachelor of Science in Engineering / full-time
Medical and Pharmaceutical Biotechnology
Master of Science in Engineering / full-time
Projects (1)
Nachhaltiges biologisches Recycling von umweltbedenklichen Stoffen (Rare Earth Elements) aus Elektronikabfall und Abwässern
Department of Life Sciences
Publications (4)
[675]
Moritz, B., Locatelli, V., Niess, M., Bathke, A., Kiessig, S., Entler, B., Finkler, C., Wegele, H., & Stracke, J. (2017): Optimization of capillary zone electrophoresis for charge heterogeneity testing of biopharmaceuticals using enhanced method development principles. Electrophoresis, 38(24): 3136–3146.
Doi: https://doi.org/10.1002/elps.201700145
[1826]
Wiesner, C., Pflueger, M., Kopecky, J., Stys, D., Entler, B., Lucas, R., Hundsberger, H., Schuett, W. (2008): Implementation of ECIS technology for the characterization of potential therapeutic drugs that promote wound-healing. GMS Krankenhaushygiene interdisziplinar, 3(1).
[622]
Wiesner, C., Pflüger, M., Kopecky, J., Stys, D., Entler, B., Lucas, R., Hundsberger, H., Schütt, W. (2008): Implementation of ECIS technology for the characterization of potential therapeutic drugs that promote wound-healing. GMS Krankenhaushygiene Interdisziplinär, 3(1): Doc05.
[1823]
Wiesner, C., Lucas, R., Pflueger, M., Kleber, C., Kopecky, J., Stys, D., Entler, B., Hundsberger, H., Atzler, J., Hrouzek, P., Lukesova, A., Schuett, W., (2007): Endothelial Cell-Based Methods for the Detection of Cyanobacterial Anti- Inflammatory and Wound-Healing Promoting Metabolites. Drug Metabolism Letters, 1(4): 254-260.
Doi: https://doi.org/10.2174/187231207783221385
Prof.(FH) Dr. Barbara Entler
E
Professor Department of Life Sciences
Prof. (FH) Dr. Maximilian Schachner
Deputy Head International Relations
International Relations
Contact
+43 2732 802 150[email protected]
Location
IMC Gozzoburg
IMC Gozzoburg
Active in the degree programmes (2)
Tourism and Leisure Management
Bachelor of Arts in Business / full-time
Medical and Pharmaceutical Biotechnology
Bachelor of Science in Engineering / full-time
Publications (1)
[261]
Schwand, C., Berger, C., Hartbach, S., Kleiss, D., Kotek, K., Kormann, G., Schachner, M., & Neuherz, C. (2011): Grundelemente der Verkaufsraumgestaltung: Die Suche nach dem Stern. In FH Campus Wien (Hrsg.), Tagungsband 5. Forschungsforum der österreichischen Fachhochschulen, 27.-28. April 2011 (-). Wien: FFH.
Prof. (FH) Dr. Maximilian Schachner
S
Deputy Head International Relations

Application and admissions – the next steps

You've found a course that's a perfect fit? Great – you’ve already taken the most important step! We’ve put together an overview to guide you through the next steps.

Admission requirements

We'll be happy to inform you about the requirements you have to meet in order to apply.

Details

Admissions procedure

Preparation is everything – read up on the admissions procedure in detail.

Details

Important dates and deadlines

What deadlines do you need to keep an eye on for your online application? Get an overview.

Details

Apply online

You've decided for one of our degree programmes? First of all: congratulations and thank you for choosing us! We’ll be happy to guide you step-by-step through your online application.

Details

Study-relevant dates

You would like to plan ahead and would like to know when your degree programme starts? Here you will find the answer!

Details

Admissions procedure

Application interview

We would like to get to know you as a person. In the course of the online application process, you will have to write a letter of motivation. This letter of motivation also contains a selection of topics with various related questions. You should select a topic, do some research in order to find additional information and answer the questions in your letter of motivation by completing the fields provided on the online application form.

Your letter of motivation forms the basis for your application interview. Every applicant has an opportunity to introduce themselves in a face-to-face discussion, usually with the degree programme director. In addition to the personal introduction, the applicant and the interviewer discuss the topic selected and the arguments used in the letter of motivation, as well as the topic’s relevance for the degree programme.

The application interview takes place in the language of instruction of the degree programme and can also be held by video call where justified.

The letter of motivation and the interview are assessed on the basis of the applicant’s content-related remarks, the manner in which they express themselves and the arguments used.

Interview dates

There is usually a selection of dates to choose from, with quotas allocated for each date. You can select a preferred date and time slot for your admission interview during the online application process. In order to still benefit from the full selection of dates, we recommend that you submit your application in good time.

Get an overview of the dates for your programme.

After you have successfully completed your online application, your application will be checked for completeness and correctness. As soon as this process is completed, we will inform you by e-mail and confirm the date for your admission interview. We will send you the Microsoft Teams Meeting Link in a separate e-mail a few days before the application interview date.

Application deadline for EU nationals / Extended application deadline	31/03/2021 / 10/05/2021
Application deadline for non-EU nationals	31/03/2021

Questions about the degree programme?

Prospective Student Advisory Service

Do you have questions regarding the entry requirements, the admission procedure and more? Our Prospective Student Advisory Service is happy to help.

Ask a Student

Join our Facebook group: Direct your questions to our students and get first-hand accounts about studying at IMC Krems.

Similar degree programmes

Applied Chemistry

The Applied Chemistry bachelor degree programme prepares students for the challenges posed by industry 4.0 in the chemicals industry.

Show details

Medical and Pharmaceutical Biotechnology bachelor degree programme

Would you like to play a part in dramatically improving the quality of life of millions of patients around the world? The Medical and Pharmaceutical Biotechnology bachelor programme will give you the opportunity to do just that.

Full-time

English

6 semesters

20 weeks

EUR 363.36

The degree programme: Bachelor of Science in Engineering (BSc)

Medical biotechnology

Pharmaceutical biotechnology

Quality management

Fundamentals of business

Biotechnology

New treatment methods

Programme director Harald Hundsberger

A formula for success: theoretical knowledge + practical experience

The basics

The internship

Electives

Curriculum

Semester 1

Introduction to Laboratory Techniques

Applied Physics - Theory

Applied Physics - Laboratory

Analytical Chemistry Laboratory

Chemical Calculations

General and Inorganic Chemistry

Applied Mathematics - Theory

Applied Mathematics - Exercise

Introduction to Data Science I

Anatomy and Physiology

Human Genetics

Applied Microbiology

Microbiological Working Techniques Laboratory

Semester 2

Organic Chemistry - Theory

Organic Chemistry - Laboratory

Biostatistics

Introduction Data Science II

Applied Biophysics

Biophysics Laboratory

Human Diseases

Immunology and Medical Microbiology

Microbiological Monitoring Laboratory

Introduction to Contamination Control and Clean Room Training

Cell Biology

Molecular Biology and Genetic Engineering - Theory

Semester 3

Instrumental Analytics - Theory

Instrumental Analytics - Laboratory

Genetic Engineering Laboratory

Biochemistry - Theory

Biochemistry - Laboratory

Bioinformatics

Cell Physiology and Medical Molecular Biology

Cell Culture Techniques

Cell Culture Laboratory I

Bioprocess Technology Theory I

Measurement and Control Systems I

Introduction to Quality Management

GLP/GMP - Theory

Practical Training Application and Preparation

Semester 4

Cell Culture Laboratory II

Scientific Skills

Biochemical Analytics, Protein Purification

Equipment and Production Design

Bioprocess Technology Theory II

Fermentation and Bioseparation Laboratory, Data Analysis

GLP/GMP - Seminar

Genetic Engineering Laboratory under GLP

Semester 5

Practical Training Semester

Bachelor Seminar I

Semester 6

Pharmacology

Current Issues in Molecular Medicine

Project Management in Life Sciences

Journal Club for Current Issues

Introduction to Validation